A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7)
Drugs that selectively bind to but do not activate HISTAMINE H3 RECEPTORS. They have been used to correct SLEEP WAKE DISORDERS and MEMORY DISORDERS.
A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H3 receptors were first recognized as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. (From Biochem Soc Trans 1992 Feb;20(1):122-5)
Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.
A prodromal phase of cognitive decline that may precede the emergence of ALZHEIMER DISEASE and other dementias. It may include impairment of cognition, such as impairments in language, visuospatial awareness, ATTENTION and MEMORY.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.
Intellectual or mental process whereby an organism obtains knowledge.
Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.
Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.
Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175)
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Learning the correct route through a maze to obtain reinforcement. It is used for human or animal populations. (Thesaurus of Psychological Index Terms, 6th ed)
The process of finding chemicals for potential therapeutic use.
A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.
Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge.
A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
Loss of higher cortical functions with retained awareness due to multiple cortical or subcortical CEREBRAL INFARCTION. Memory, judgment, attention span, and impulse control are often impaired, and may be accompanied by PSEUDOBULBAR PALSY; HEMIPARESIS; reflex abnormalities, and other signs of localized neurologic dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p1060)
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Those disorders that have a disturbance in mood as their predominant feature.
The physical activity of a human or an animal as a behavioral phenomenon.
Evaluation of the level of physical, physiological, or mental functioning in the older population group.
A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
Persistent and disabling ANXIETY.
A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES.
A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.
Categorical classification of MENTAL DISORDERS based on criteria sets with defining features. It is produced by the American Psychiatric Association. (DSM-IV, page xxii)
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation.
Standardized clinical interview used to assess current psychopathology by scaling patient responses to the questions.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Lists of words to which individuals are asked to respond ascertaining the conceptual meaning held by the individual.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Studies in which variables relating to an individual or group of individuals are assessed over a period of time.
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
Hospital units providing continuous surveillance and care to acutely ill patients.
A progressive form of dementia characterized by the global loss of language abilities and initial preservation of other cognitive functions. Fluent and nonfluent subtypes have been described. Eventually a pattern of global cognitive dysfunction, similar to ALZHEIMER DISEASE, emerges. Pathologically, there are no Alzheimer or PICK DISEASE like changes, however, spongiform changes of cortical layers II and III are present in the TEMPORAL LOBE and FRONTAL LOBE. (From Brain 1998 Jan;121(Pt 1):115-26)
Lower lateral part of the cerebral hemisphere responsible for auditory, olfactory, and semantic processing. It is located inferior to the lateral fissure and anterior to the OCCIPITAL LOBE.
The process whereby a representation of past experience is elicited.
Persons who provide care to those who need supervision or assistance in illness or disability. They may provide the care in the home, in a hospital, or in an institution. Although caregivers include trained medical, nursing, and other health personnel, the concept also refers to parents, spouses, or other family members, friends, members of the clergy, teachers, social workers, fellow patients.
Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.
Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES).
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
A technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.
Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization.
The subject's ability to connect 25 numbered and lettered circles in sequence in a specific length of time. A score of 12 or below is suggestive of organic brain damage.
Procedure in which an individual is induced into a trance-like state to relieve pain. This procedure is frequently performed with local but not general ANESTHESIA.
Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
The performance of the basic activities of self care, such as dressing, ambulation, or eating.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Loss of the ability to form new memories beyond a certain point in time. This condition may be organic or psychogenic in origin. Organically induced anterograde amnesia may follow CRANIOCEREBRAL TRAUMA; SEIZURES; ANOXIA; and other conditions which adversely affect neural structures associated with memory formation (e.g., the HIPPOCAMPUS; FORNIX (BRAIN); MAMMILLARY BODIES; and ANTERIOR THALAMIC NUCLEI). (From Memory 1997 Jan-Mar;5(1-2):49-71)
A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.
A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
The caring for individuals in institutions and their adaptation to routines characteristic of the institutional environment, and/or their loss of adaptation to life outside the institution.
Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
Type of declarative memory, consisting of personal memory in contrast to general knowledge.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Conclusions derived from the nursing assessment that establish a health status profile for the patient and from which nursing interventions may be ordered.
Learning to respond verbally to a verbal stimulus cue.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
Evaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
A disease or state in which death is possible or imminent.
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.
An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
Elements of limited time intervals, contributing to particular results or situations.
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
A group of mental disorders associated with organic brain damage and caused by poisoning from alcohol.
Geriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.
Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
Disorders related to substance abuse.
Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
A mental disorder associated with chronic ethanol abuse (ALCOHOLISM) and nutritional deficiencies characterized by short term memory loss, confabulations, and disturbances of attention. (Adams et al., Principles of Neurology, 6th ed, p1139)
A subspecialty of psychiatry concerned with the mental health of the aged.
The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulchi. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
Non-invasive methods of visualizing the CENTRAL NERVOUS SYSTEM, especially the brain, by various imaging modalities.
A physical property showing different values in relation to the direction in or along which the measurement is made. The physical property may be with regard to thermal or electric conductivity or light refraction. In crystallography, it describes crystals whose index of refraction varies with the direction of the incident light. It is also called acolotropy and colotropy. The opposite of anisotropy is isotropy wherein the same values characterize the object when measured along axes in all directions.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
Advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring. It is usually administered in specially equipped units of a health care facility.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
The branch of medicine concerned with the physiological and pathological aspects of the aged, including the clinical problems of senescence and senility.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
Older adults or aged individuals who are lacking in general strength and are unusually susceptible to disease or to other infirmity.
The knowledge or perception that someone or something present has been previously encountered.
The use of diffusion ANISOTROPY data from diffusion magnetic resonance imaging results to construct images based on the direction of the faster diffusing molecules.
Intracytoplasmic, eosinophilic, round to elongated inclusions found in vacuoles of injured or fragmented neurons. The presence of Lewy bodies is the histological marker of the degenerative changes in LEWY BODY DISEASE and PARKINSON DISEASE but they may be seen in other neurological conditions. They are typically found in the substantia nigra and locus coeruleus but they are also seen in the basal forebrain, hypothalamic nuclei, and neocortex.

Evaluation of regional cerebral blood flow with 99mTc-HMPAO in primary antiphospholipid antibody syndrome. (1/248)

In this study, 99mTc-hexamethyl propyleneamine oxime (HMPAO) SPECT was used to evaluate the regional cerebral blood flow (rCBF) of the brain in patients with primary antiphospholipid antibody syndrome (PAPS). METHODS: Twenty-two women who were PAPS patients, aged 28-60 y, with mild neuropsychiatric manifestations and normal brain MRI findings were enrolled in this study. Brain HMPAO SPECT was performed to detect brain abnormalities. Meanwhile, serum anticardiolipin antibodies (ACA) and lupus anticoagulant (LA) were measured. RESULTS: HMPAO SPECT revealed hypoperfusion lesions in 16 of 22 (73%) PAPS patients. Cerebral cortex and cerebellum were the most and the least commonly involved areas, respectively. Eighteen of 22 (82%) and 14 of 22 (64%) patients had positive ACA and positive LA, respectively. ACA and LA results were related to HMPAO SPECT findings. CONCLUSION: HMPAO SPECT is a sensitive tool for detecting brain abnormalities in PAPS patients with only mild neuropsychiatric manifestations and normal brain MRI findings.  (+info)

Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine. (2/248)

A 34-year-old man with a 10-year history of persistent auditory hallucinations and passivity delusions had failed to respond to a variety of conventional antipsychotic medications. He had a history of head trauma 8 years before the onset of psychiatric symptoms. Recent investigations revealed a post-traumatic infarct, situated in the left frontal lobe, on a magnetic resonance imaging scan. Treatment with clozapine for more than 2 years resulted in a marked improvement in his psychotic symptoms. The localization of the brain lesion may be related to the etiology of his symptoms and to the clinical response to clozapine.  (+info)

Diagnostic differences in psychogeriatric patients in Toronto, New York and London, England. (3/248)

National statistics on psychiatric illness in the elderly patient from Canada, the United States and the United Kingdom suggest great differences in morbidity in these three centres. The present study shows that these differences stem mainly from different diagnostic habits in the three countries, but also there were more alcoholics in the Canadian sample. In particular, the diagnostic bias of the New York psychiatrists towards diagnosing most elderly patients as senile was not shared by their Toronto colleagues. Some patients were psychiatrically well, in spite of receiving a psychiatric diagnosis, and could have been helped without hospitalization. In addition, some depressed patients were labelled senile. Recommendations include improvement of catchment and treatment facilities for the elderly alcoholic and the provision of psychogeriatric diagnostic centres.  (+info)

Childhood organic neurological disease presenting as psychiatric disorder. (4/248)

Over a period of one year 12 children with complaints which had been diagnosed as due to a psychiatric disorder presented to a paediatric neurological unit where neurological disease was diagnosed. The group was characterized by behavioural symptoms such as deteriorating school performance, visual loss, and postural disturbance, which are unusual in children attending child psychiatric departments. It is suggested that where there is diagnostic uncertainty the presence of these physical symptoms calls for periodic neurological reassessment, and attention is drawn to the rare but serious disorders which may thus be diagnosed. Making an organic diagnosis, however, should not preclude psychosocial management of emotional reactions in these families.  (+info)

New-onset delusions and hallucinations in patients infected with HIV. (5/248)

OBJECTIVE: To assess the relationship between HIV-associated psychotic symptoms (i.e., delusions, hallucinations) and demographic, psychopathological and medical variables by comparing patients with and without cerebral opportunistic infections or metabolic encephalopathy. DESIGN: Cross-sectional study. PATIENTS: 26 patients admitted to hospital with HIV and new-onset psychotic symptoms, defined according to DSM-III-R criteria. OUTCOME MEASURES: A semistructured psychiatric interview using the Psychopathology Assessment Scale (AMDP-4) of the Association for Methodology and Documentation in Psychiatry system. Comprehensive medical assessments, including laboratory tests and computed tomographic scans, were also performed. RESULTS: Patients with cerebral opportunistic infections or metabolic encephalopathy (i.e., "secondary" psychosis, n = 13) were more likely to show disorders of consciousness, disorders of orientation and disturbances of attention and memory than those with no evidence of HIV-related cerebral disease (i.e., "primary" psychosis, n = 13); 10 patients (77%) with cerebral opportunistic infections or metabolic encephalopathy and only 1 (8%) patient without (p < 0.001) were diagnosed with delirium. These associations were stronger for the "secondary" patients with no focal brain lesions than for those with lesions. CONCLUSIONS: These findings suggest that "organic" symptoms of psychosis in those infected with HIV are related to the systemic and cerebral complications of HIV infection rather than to the psychotic process itself.  (+info)

Analysis of intellectual and cognitive performance in patients with multi-infarct dementia, vertebrobasilar insufficiency with dementia, and Alzheimer's disease. (6/248)

A prominent feature in dementia is intellectual deterioration. Review of the clinical literature indicates a lack of suitably quantitated studies of specific intellectual defects in dementia. The present study investigated the performance of patients with multi-infarct dementia (MID), dementia due to Alzheimer's disease (AD), and vertebrobasilar insufficiency (VBI) with dementia using the Wechsler Adult Intelligence Scale (WAIS). Forty-two patients ranging in age from 45 to 85 years (x 66) were included. Significant differences in cognitive and intellectual performance were found between patients with dementia due to VBI and MID versus neuronal atrophy of the Alzheimer's type. The group with AD performed significantly and consistently lower on all measures. There were no significant differences between the two cerebrovascular disease groups, even though the MID group performed consistently more poorly than the VBI group. A discriminant function analysis classified 74% of the patients correctly based on the individual WAIS scores. The diagnosis was more easily made when tasks measuring visual motor coordination and abstract reasoning were included in the analysis.  (+info)

Regional cerebral blood flow estimated by 133-xenon inhalation. (7/248)

A method is described for estimating the clearance rate and fractional blood flow of the fast (gray matter) compartment of the brain from the first ten minutes of 122 XE clearance curves, following a one-minute inhalation. Computer-simulated data were used to test the adequacy of the two-compartmental model employed, and to evaluate the stability of the parameters in the presence of random noise. A comparison was made between this approach and the previously reported three-compartmental analysis. Regional cerbral blood flow data were obtained on 48 young control subjects and 20 elderly demented patients. Hemispheral, regional, and test-retest variations were determined, as well as differences between the groups.  (+info)

Cognitive impairment, depressive symptoms, and functional decline in older people. (8/248)

OBJECTIVES: Although cognitive impairment and depressive symptoms are associated with functional decline, it is not understood how these risk factors act together to affect the risk of functional decline. The purpose of this study is to determine the relative contributions of cognitive impairment and depressive symptoms on decline in activity of daily living (ADL) function over 2 years in an older cohort. DESIGN: Prospective cohort study. SETTING: A U.S. national prospective cohort study of older people, Asset and Health Dynamics in the Oldest Old. PARTICIPANTS: Five thousand six hundred ninety-seven participants (mean age 77, 64% women, 86% white) followed from 1993 to 1995. MEASUREMENTS: Cognitive impairment and depressive symptoms were defined as the poorest scores: 1.5 standard deviations below the mean on a cognitive scale or 1.5 standard deviations above the mean on validated depression scales. Risk of functional decline in participants with depressive symptoms, cognitive impairment, and both, compared with neither risk factor, were calculated and stratified by baseline dependence. Analyses were adjusted for demographics and comorbidity. RESULTS: Eight percent (n = 450) of subjects declined in ADL function. In participants who were independent in all ADLs at baseline, the relative risk (RR) of 2-year functional decline was 2.3 (95% confidence interval (CI) = 1.7-3.1) for participants with cognitive impairment, 1.9 (95% CI = 1.3-2.6) for participants with depressive symptoms, and 2.4 (95% CI = 1.4-3.7) for participants with cognitive impairment and depressive symptoms. In participants who were dependent in one or more ADLs at baseline, RR of 2-year functional decline was 1.9 (95% CI = 1.2-2.8) for participants with cognitive impairment, 0.6 (95% CI = 0.3-1.3) for participants with depressive symptoms, and 1.5 (95% CI = 0.8-2.6) for participants with cognitive impairment and depressive symptoms. CONCLUSIONS: In participants with no ADL dependence at baseline, cognitive impairment and depressive symptoms are risk factors for decline, but that, in participants with dependence in ADL at baseline, cognitive impairment, but not depressive symptoms, is a risk factor for additional decline.  (+info)

Delirium is a serious disturbance in mental abilities that results in confused thinking and reduced awareness of the environment, which can cause people to be easily distracted and unable to focus on any one topic for very long. It can also lead to rapid changes in emotions, perception, behavior, sleep-wake cycle, and hallucinations. Delirium is caused by various underlying medical conditions, such as infection, illness, or medication side effects, and it can be a symptom of severe illness or brain disorder. It can develop quickly, often over the course of hours or days, and it may come and go.

Delirium is different from dementia, which is a chronic and progressive decline in cognitive abilities, although delirium can occur in people with dementia. Delirium is also different from a mental illness such as schizophrenia, which involves persistent disturbances in thinking and perception that are not caused by a medical condition or medication.

Delirium is a serious medical condition that requires immediate evaluation and treatment. If you suspect someone may have delirium, it's important to seek medical attention right away.

Dementia is a broad term that describes a decline in cognitive functioning, including memory, language, problem-solving, and judgment, severe enough to interfere with daily life. It is not a specific disease but rather a group of symptoms that may be caused by various underlying diseases or conditions. Alzheimer's disease is the most common cause of dementia, accounting for 60-80% of cases. Other causes include vascular dementia, Lewy body dementia, frontotemporal dementia, and Huntington's disease.

The symptoms of dementia can vary widely depending on the cause and the specific areas of the brain that are affected. However, common early signs of dementia may include:

* Memory loss that affects daily life
* Difficulty with familiar tasks
* Problems with language or communication
* Difficulty with visual and spatial abilities
* Misplacing things and unable to retrace steps
* Decreased or poor judgment
* Withdrawal from work or social activities
* Changes in mood or behavior

Dementia is a progressive condition, meaning that symptoms will gradually worsen over time. While there is currently no cure for dementia, early diagnosis and treatment can help slow the progression of the disease and improve quality of life for those affected.

Cognitive disorders are a category of mental health disorders that primarily affect cognitive abilities including learning, memory, perception, and problem-solving. These disorders can be caused by various factors such as brain injury, degenerative diseases, infection, substance abuse, or developmental disabilities. Examples of cognitive disorders include dementia, amnesia, delirium, and intellectual disability. It's important to note that the specific definition and diagnostic criteria for cognitive disorders may vary depending on the medical source or classification system being used.

Amnesia is a condition characterized by memory loss, which can be temporary or permanent. It may result from brain damage or disease, and it can affect various aspects of memory, such as the ability to recall past events (retrograde amnesia), the ability to form new memories (anterograde amnesia), or both. Amnesia can also affect a person's sense of identity and their ability to learn new skills.

There are several types of amnesia, including:

1. Anterograde amnesia: This type of amnesia affects the ability to form new memories after an injury or trauma. People with anterograde amnesia may have difficulty learning new information and remembering recent events.
2. Retrograde amnesia: Retrograde amnesia affects the ability to recall memories that were formed before an injury or trauma. People with retrograde amnesia may have trouble remembering events, people, or facts from their past.
3. Transient global amnesia: This is a temporary form of amnesia that usually lasts for less than 24 hours. It is often caused by a lack of blood flow to the brain, and it can be triggered by emotional stress, physical exertion, or other factors.
4. Korsakoff's syndrome: This is a type of amnesia that is caused by alcohol abuse and malnutrition. It is characterized by severe memory loss, confusion, and disorientation.
5. Dissociative amnesia: This type of amnesia is caused by psychological factors, such as trauma or stress. People with dissociative amnesia may have trouble remembering important personal information or events that are emotionally charged.

The treatment for amnesia depends on the underlying cause. In some cases, memory may improve over time, while in other cases, it may be permanent. Treatment may involve medication, therapy, or rehabilitation to help people with amnesia cope with their memory loss and develop new skills to compensate for their memory impairments.

Histamine H3 antagonists, also known as inverse agonists, are a class of drugs that block the activity of histamine at the H3 receptor. Histamine is a naturally occurring neurotransmitter and autacoid involved in various physiological functions, including the modulation of wakefulness and arousal, regulation of food intake, and control of blood pressure and fluid balance.

The H3 receptor is primarily located in the central nervous system (CNS) and acts as an auto-receptor on histamine-containing neurons to regulate the release of histamine. By blocking the activity of these receptors, histamine H3 antagonists increase the release of histamine in the CNS, which can lead to increased wakefulness and arousal.

Histamine H3 antagonists have been studied for their potential therapeutic use in various neurological and psychiatric disorders, including narcolepsy, attention deficit hyperactivity disorder (ADHD), and Alzheimer's disease. However, further research is needed to fully understand the clinical benefits and safety of these drugs.

Histamine H3 receptors are a type of G protein-coupled receptor (GPCR) that are widely distributed throughout the central and peripheral nervous system. They are activated by the neurotransmitter histamine and function as autoreceptors, inhibiting the release of histamine from presynaptic nerve terminals. Histamine H3 receptors also modulate the activity of other neurotransmitters, such as acetylcholine, dopamine, norepinephrine, and serotonin, by regulating their synthesis, release, and uptake.

Histamine H3 receptors have been identified as potential targets for the treatment of various neurological and psychiatric disorders, including sleep disorders, attention deficit hyperactivity disorder (ADHD), schizophrenia, and drug addiction. Antagonists or inverse agonists of Histamine H3 receptors may enhance the release of neurotransmitters in the brain, leading to improved cognitive function, mood regulation, and reward processing. However, further research is needed to fully understand the therapeutic potential and safety profile of Histamine H3 receptor modulators.

Neuropsychological tests are a type of psychological assessment that measures cognitive functions, such as attention, memory, language, problem-solving, and perception. These tests are used to help diagnose and understand the cognitive impact of neurological conditions, including dementia, traumatic brain injury, stroke, Parkinson's disease, and other disorders that affect the brain.

The tests are typically administered by a trained neuropsychologist and can take several hours to complete. They may involve paper-and-pencil tasks, computerized tasks, or interactive activities. The results of the tests are compared to normative data to help identify any areas of cognitive weakness or strength.

Neuropsychological testing can provide valuable information for treatment planning, rehabilitation, and assessing response to treatment. It can also be used in research to better understand the neural basis of cognition and the impact of neurological conditions on cognitive function.

Mild Cognitive Impairment (MCI) is a medical term used to describe a stage between the cognitive changes seen in normal aging and the more serious decline of dementia. It's characterized by a slight but noticeable decline in cognitive abilities, such as memory or thinking skills, that are greater than expected for an individual's age and education level, but not significant enough to interfere with daily life.

People with MCI have an increased risk of developing dementia, particularly Alzheimer's disease, compared to those without MCI. However, it's important to note that not everyone with MCI will develop dementia; some may remain stable, and others may even improve over time.

The diagnosis of MCI is typically made through a comprehensive medical evaluation, including a detailed medical history, cognitive testing, and sometimes brain imaging or laboratory tests.

Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. It's the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to function independently.

The early signs of the disease include forgetting recent events or conversations. As the disease progresses, a person with Alzheimer's disease will develop severe memory impairment and lose the ability to carry out everyday tasks.

Currently, there's no cure for Alzheimer's disease. However, treatments can temporarily slow the worsening of dementia symptoms and improve quality of life.

Vascular dementia is a type of dementia that is caused by damage to the blood vessels that supply blood to the brain. This damage can result from conditions such as stroke, chronic high blood pressure, diabetes, or other diseases that affect the circulatory system. The interruption in blood flow to the brain can lead to damaged or dead brain cells, which can impair cognitive function and cause symptoms similar to those seen in other types of dementia, such as Alzheimer's disease.

The symptoms of vascular dementia can vary depending on the severity and location of the damage to the blood vessels. However, common symptoms include difficulties with memory, attention, and decision-making; problems with language and speech; changes in mood or behavior; and difficulty walking or performing other physical tasks. Vascular dementia is typically a progressive condition, meaning that the symptoms tend to worsen over time.

It's important to note that vascular dementia can coexist with other types of dementia, such as Alzheimer's disease, and this is known as mixed dementia. Proper diagnosis and management of underlying medical conditions that contribute to vascular dementia can help slow down the progression of cognitive decline and improve quality of life for individuals living with this condition.

Nootropic agents, also known as cognition enhancers or smart drugs, are substances that are believed to improve cognitive functions such as memory, motivation, creativity, and executive functions. The term "nootropic" is derived from the Greek words "nous," meaning mind, and "tropos," meaning a turn or bend.

Nootropics can be divided into several categories, including dietary supplements, prescription medications, and illicit substances. Some examples of nootropics include:

* Piracetam and other racetams
* Caffeine and other stimulants
* Nicotine and other cholinergic compounds
* Modafinil and other wakefulness-promoting agents
* Certain antidepressants, such as fluoxetine and bupropion
* Illicit substances, such as methylphenidate (Ritalin) and amphetamines (Adderall), which are sometimes used off-label for cognitive enhancement.

It is important to note that while some nootropic agents have been shown to have cognitive benefits in certain studies, their effectiveness and safety are not fully understood. Additionally, the long-term use of some nootropics can have potential risks and side effects. Therefore, it is recommended to consult with a healthcare professional before starting any new supplement or medication regimen for cognitive enhancement.

Cognition refers to the mental processes involved in acquiring, processing, and utilizing information. These processes include perception, attention, memory, language, problem-solving, and decision-making. Cognitive functions allow us to interact with our environment, understand and respond to stimuli, learn new skills, and remember experiences.

In a medical context, cognitive function is often assessed as part of a neurological or psychiatric evaluation. Impairments in cognition can be caused by various factors, such as brain injury, neurodegenerative diseases (e.g., Alzheimer's disease), infections, toxins, and mental health conditions. Assessing cognitive function helps healthcare professionals diagnose conditions, monitor disease progression, and develop treatment plans.

Memory disorders are a category of cognitive impairments that affect an individual's ability to acquire, store, retain, and retrieve memories. These disorders can be caused by various underlying medical conditions, including neurological disorders, psychiatric illnesses, substance abuse, or even normal aging processes. Some common memory disorders include:

1. Alzheimer's disease: A progressive neurodegenerative disorder that primarily affects older adults and is characterized by a decline in cognitive abilities, including memory, language, problem-solving, and decision-making skills.
2. Dementia: A broader term used to describe a group of symptoms associated with a decline in cognitive function severe enough to interfere with daily life. Alzheimer's disease is the most common cause of dementia, but other causes include vascular dementia, Lewy body dementia, and frontotemporal dementia.
3. Amnesia: A memory disorder characterized by difficulties in forming new memories or recalling previously learned information due to brain damage or disease. Amnesia can be temporary or permanent and may result from head trauma, stroke, infection, or substance abuse.
4. Mild cognitive impairment (MCI): A condition where an individual experiences mild but noticeable memory or cognitive difficulties that are greater than expected for their age and education level. While some individuals with MCI may progress to dementia, others may remain stable or even improve over time.
5. Korsakoff's syndrome: A memory disorder often caused by alcohol abuse and thiamine deficiency, characterized by severe short-term memory loss, confabulation (making up stories to fill in memory gaps), and disorientation.

It is essential to consult a healthcare professional if you or someone you know experiences persistent memory difficulties, as early diagnosis and intervention can help manage symptoms and improve quality of life.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

Histamine antagonists, also known as histamine blockers or H1-blockers, are a class of medications that work by blocking the action of histamine, a substance in the body that is released during an allergic reaction. Histamine causes many of the symptoms of an allergic response, such as itching, sneezing, runny nose, and hives. By blocking the effects of histamine, these medications can help to relieve or prevent allergy symptoms.

Histamine antagonists are often used to treat conditions such as hay fever, hives, and other allergic reactions. They may also be used to treat stomach ulcers caused by excessive production of stomach acid. Some examples of histamine antagonists include diphenhydramine (Benadryl), loratadine (Claritin), and famotidine (Pepcid).

It's important to note that while histamine antagonists can be effective at relieving allergy symptoms, they do not cure allergies or prevent the release of histamine. They simply block its effects. It's also worth noting that these medications can have side effects, such as drowsiness, dry mouth, and dizziness, so it's important to follow your healthcare provider's instructions carefully when taking them.

Delirium, Dementia, Amnestic, and Other Cognitive Disorders are conditions that affect cognitive abilities such as thinking, memory, perception, and judgment. Here are brief medical definitions of each:

1. Delirium: A serious disturbance in mental abilities that results in confused thinking and reduced awareness of the environment. It can cause hallucinations, delusions, and disorientation. Delirium often comes on suddenly and can be caused by various factors such as medication side effects, infection, or illness.
2. Dementia: A chronic and progressive decline in cognitive abilities that affects memory, language, problem-solving, and judgment. Alzheimer's disease is the most common cause of dementia, but other conditions such as vascular dementia, Lewy body dementia, and frontotemporal dementia can also cause it. Dementia can significantly interfere with daily life and activities.
3. Amnestic Disorders: A group of conditions that primarily affect memory. These disorders can be caused by brain injury, illness, or substance abuse. The most common amnestic disorder is Korsakoff's syndrome, which is caused by alcohol abuse and results in significant memory loss and confusion.
4. Other Cognitive Disorders: This category includes a range of conditions that affect cognitive abilities but do not fit into the categories of delirium, dementia, or amnestic disorders. Examples include mild cognitive impairment (MCI), which is a decline in cognitive abilities that does not interfere significantly with daily life, and various cognitive disorders caused by brain injury or disease.

It's important to note that these conditions can overlap and may co-occur with other mental health or neurological disorders. Proper diagnosis and treatment require a comprehensive evaluation by a qualified healthcare professional.

In the context of medical and clinical neuroscience, memory is defined as the brain's ability to encode, store, retain, and recall information or experiences. Memory is a complex cognitive process that involves several interconnected regions of the brain and can be categorized into different types based on various factors such as duration and the nature of the information being remembered.

The major types of memory include:

1. Sensory memory: The shortest form of memory, responsible for holding incoming sensory information for a brief period (less than a second to several seconds) before it is either transferred to short-term memory or discarded.
2. Short-term memory (also called working memory): A temporary storage system that allows the brain to hold and manipulate information for approximately 20-30 seconds, although this duration can be extended through rehearsal strategies. Short-term memory has a limited capacity, typically thought to be around 7±2 items.
3. Long-term memory: The memory system responsible for storing large amounts of information over extended periods, ranging from minutes to a lifetime. Long-term memory has a much larger capacity compared to short-term memory and is divided into two main categories: explicit (declarative) memory and implicit (non-declarative) memory.

Explicit (declarative) memory can be further divided into episodic memory, which involves the recollection of specific events or episodes, including their temporal and spatial contexts, and semantic memory, which refers to the storage and retrieval of general knowledge, facts, concepts, and vocabulary, independent of personal experience or context.

Implicit (non-declarative) memory encompasses various forms of learning that do not require conscious awareness or intention, such as procedural memory (skills and habits), priming (facilitated processing of related stimuli), classical conditioning (associative learning), and habituation (reduced responsiveness to repeated stimuli).

Memory is a crucial aspect of human cognition and plays a significant role in various aspects of daily life, including learning, problem-solving, decision-making, social interactions, and personal identity. Memory dysfunction can result from various neurological and psychiatric conditions, such as dementia, Alzheimer's disease, stroke, traumatic brain injury, and depression.

Nervous system diseases, also known as neurological disorders, refer to a group of conditions that affect the nervous system, which includes the brain, spinal cord, nerves, and muscles. These diseases can affect various functions of the body, such as movement, sensation, cognition, and behavior. They can be caused by genetics, infections, injuries, degeneration, or tumors. Examples of nervous system diseases include Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, migraine, stroke, and neuroinfections like meningitis and encephalitis. The symptoms and severity of these disorders can vary widely, ranging from mild to severe and debilitating.

Alcohol withdrawal delirium, also known as delirium tremens (DTs), is a serious and potentially life-threatening complication that can occur in people who are dependent on alcohol and suddenly stop or significantly reduce their consumption. It is a form of alcohol withdrawal syndrome that is characterized by the sudden onset of severe confusion, agitation, hallucinations, tremors, and autonomic hyperactivity.

The diagnostic criteria for alcohol withdrawal delirium, as outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), include:

1. Disturbance in consciousness (i.e., reduced clarity of awareness of the environment) with reduced ability to focus, sustain, or shift attention.
2. A change in cognition (such as memory deficit, disorientation, or language disturbance) or the development of a perceptual disturbance that is not better explained by another medical condition or substance use disorder.
3. The disturbance develops over a short period of time (usually hours to a few days) and tends to fluctuate throughout the day.
4. There is evidence from the history, physical examination, or laboratory findings that the symptoms are caused by alcohol withdrawal.
5. The symptoms cannot be better explained by another medical condition, medication use, or substance intoxication or withdrawal.

Alcohol withdrawal delirium is a medical emergency and requires immediate treatment in a hospital setting. Treatment typically involves the use of medications to manage symptoms, such as benzodiazepines to reduce agitation and prevent seizures, and antipsychotic medications to treat hallucinations and delusions. Supportive care, such as fluid and electrolyte replacement, may also be necessary to prevent dehydration and other complications.

Aging is a complex, progressive and inevitable process of bodily changes over time, characterized by the accumulation of cellular damage and degenerative changes that eventually lead to increased vulnerability to disease and death. It involves various biological, genetic, environmental, and lifestyle factors that contribute to the decline in physical and mental functions. The medical field studies aging through the discipline of gerontology, which aims to understand the underlying mechanisms of aging and develop interventions to promote healthy aging and extend the human healthspan.

Maze learning is not a medical term per se, but it is a concept that is often used in the field of neuroscience and psychology. It refers to the process by which an animal or human learns to navigate through a complex environment, such as a maze, in order to find its way to a goal or target.

Maze learning involves several cognitive processes, including spatial memory, learning, and problem-solving. As animals or humans navigate through the maze, they encode information about the location of the goal and the various landmarks within the environment. This information is then used to form a cognitive map that allows them to navigate more efficiently in subsequent trials.

Maze learning has been widely used as a tool for studying learning and memory processes in both animals and humans. For example, researchers may use maze learning tasks to investigate the effects of brain damage or disease on cognitive function, or to evaluate the efficacy of various drugs or interventions for improving cognitive performance.

Drug discovery is the process of identifying new chemical entities or biological agents that have the potential to be used as therapeutic or preventive treatments for diseases. This process involves several stages, including target identification, lead identification, hit-to-lead optimization, lead optimization, preclinical development, and clinical trials.

Target identification is the initial stage of drug discovery, where researchers identify a specific molecular target, such as a protein or gene, that plays a key role in the disease process. Lead identification involves screening large libraries of chemical compounds or natural products to find those that interact with the target molecule and have potential therapeutic activity.

Hit-to-lead optimization is the stage where researchers optimize the chemical structure of the lead compound to improve its potency, selectivity, and safety profile. Lead optimization involves further refinement of the compound's structure to create a preclinical development candidate. Preclinical development includes studies in vitro (in test tubes or petri dishes) and in vivo (in animals) to evaluate the safety, efficacy, and pharmacokinetics of the drug candidate.

Clinical trials are conducted in human volunteers to assess the safety, tolerability, and efficacy of the drug candidate in treating the disease. If the drug is found to be safe and effective in clinical trials, it may be approved by regulatory agencies such as the U.S. Food and Drug Administration (FDA) for use in patients.

Overall, drug discovery is a complex and time-consuming process that requires significant resources, expertise, and collaboration between researchers, clinicians, and industry partners.

The hippocampus is a complex, curved formation in the brain that resembles a seahorse (hence its name, from the Greek word "hippos" meaning horse and "kampos" meaning sea monster). It's part of the limbic system and plays crucial roles in the formation of memories, particularly long-term ones.

This region is involved in spatial navigation and cognitive maps, allowing us to recognize locations and remember how to get to them. Additionally, it's one of the first areas affected by Alzheimer's disease, which often results in memory loss as an early symptom.

Anatomically, it consists of two main parts: the Ammon's horn (or cornu ammonis) and the dentate gyrus. These structures are made up of distinct types of neurons that contribute to different aspects of learning and memory.

Atrophy is a medical term that refers to the decrease in size and wasting of an organ or tissue due to the disappearance of cells, shrinkage of cells, or decreased number of cells. This process can be caused by various factors such as disuse, aging, degeneration, injury, or disease.

For example, if a muscle is immobilized for an extended period, it may undergo atrophy due to lack of use. Similarly, certain medical conditions like diabetes, cancer, and heart failure can lead to the wasting away of various tissues and organs in the body.

Atrophy can also occur as a result of natural aging processes, leading to decreased muscle mass and strength in older adults. In general, atrophy is characterized by a decrease in the volume or weight of an organ or tissue, which can have significant impacts on its function and overall health.

In the context of medicine and healthcare, learning is often discussed in relation to learning abilities or disabilities that may impact an individual's capacity to acquire, process, retain, and apply new information or skills. Learning can be defined as the process of acquiring knowledge, understanding, behaviors, and skills through experience, instruction, or observation.

Learning disorders, also known as learning disabilities, are a type of neurodevelopmental disorder that affects an individual's ability to learn and process information in one or more areas, such as reading, writing, mathematics, or reasoning. These disorders are not related to intelligence or motivation but rather result from differences in the way the brain processes information.

It is important to note that learning can also be influenced by various factors, including age, cognitive abilities, physical and mental health status, cultural background, and educational experiences. Therefore, a comprehensive assessment of an individual's learning abilities and needs should take into account these various factors to provide appropriate support and interventions.

Bipolar disorder, also known as manic-depressive illness, is a mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). When you become depressed, you may feel sad or hopeless and lose interest or pleasure in most activities. When your mood shifts to mania or hypomania (a less severe form of mania), you may feel euphoric, full of energy, or unusually irritable. These mood swings can significantly affect your job, school, relationships, and overall quality of life.

Bipolar disorder is typically characterized by the presence of one or more manic or hypomanic episodes, often accompanied by depressive episodes. The episodes may be separated by periods of normal mood, but in some cases, a person may experience rapid cycling between mania and depression.

There are several types of bipolar disorder, including:

* Bipolar I Disorder: This type is characterized by the occurrence of at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes.
* Bipolar II Disorder: This type involves the presence of at least one major depressive episode and at least one hypomanic episode, but no manic episodes.
* Cyclothymic Disorder: This type is characterized by numerous periods of hypomania and depression that are not severe enough to meet the criteria for a full manic or depressive episode.
* Other Specified and Unspecified Bipolar and Related Disorders: These categories include bipolar disorders that do not fit the criteria for any of the other types.

The exact cause of bipolar disorder is unknown, but it appears to be related to a combination of genetic, environmental, and neurochemical factors. Treatment typically involves a combination of medication, psychotherapy, and lifestyle changes to help manage symptoms and prevent relapses.

Psychiatric Status Rating Scales are standardized assessment tools used by mental health professionals to evaluate and rate the severity of a person's psychiatric symptoms and functioning. These scales provide a systematic and structured approach to measuring various aspects of an individual's mental health, such as mood, anxiety, psychosis, behavior, and cognitive abilities.

The purpose of using Psychiatric Status Rating Scales is to:

1. Assess the severity and improvement of psychiatric symptoms over time.
2. Aid in diagnostic decision-making and treatment planning.
3. Monitor treatment response and adjust interventions accordingly.
4. Facilitate communication among mental health professionals about a patient's status.
5. Provide an objective basis for research and epidemiological studies.

Examples of Psychiatric Status Rating Scales include:

1. Clinical Global Impression (CGI): A brief, subjective rating scale that measures overall illness severity, treatment response, and improvement.
2. Positive and Negative Syndrome Scale (PANSS): A comprehensive scale used to assess the symptoms of psychosis, including positive, negative, and general psychopathology domains.
3. Hamilton Rating Scale for Depression (HRSD) or Montgomery-Åsberg Depression Rating Scale (MADRS): Scales used to evaluate the severity of depressive symptoms.
4. Young Mania Rating Scale (YMRS): A scale used to assess the severity of manic or hypomanic symptoms.
5. Brief Psychiatric Rating Scale (BPRS) or Symptom Checklist-90 Revised (SCL-90-R): Scales that measure a broad range of psychiatric symptoms and psychopathology.
6. Global Assessment of Functioning (GAF): A scale used to rate an individual's overall psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.

It is important to note that Psychiatric Status Rating Scales should be administered by trained mental health professionals to ensure accurate and reliable results.

A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.

Multi-infarct dementia (MID) is a specific type of dementia that is caused by multiple small strokes or mini-strokes (known as transient ischemic attacks or TIAs) in the brain. Also known as vascular dementia, multi-infarct dementia results from the interruption of blood flow to parts of the brain, leading to damage and death of brain tissue.

The term 'multi-infarct' refers to multiple areas (or infarcts) of damaged or dead tissue in the brain due to the lack of oxygen and nutrients caused by these small strokes. Over time, as more areas of the brain are affected, cognitive decline becomes apparent, leading to symptoms such as memory loss, difficulty with problem-solving, disorientation, language problems, and changes in mood or behavior.

Multi-infarct dementia is typically a progressive condition, meaning that symptoms worsen over time. However, the rate of progression can vary depending on factors such as the number and severity of strokes, underlying medical conditions, and lifestyle factors. It's important to note that multi-infarct dementia can be prevented or delayed by controlling risk factors for stroke, such as high blood pressure, diabetes, smoking, and high cholesterol.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

Mood disorders are a category of mental health disorders characterized by significant and persistent changes in mood, affect, and emotional state. These disorders can cause disturbances in normal functioning and significantly impair an individual's ability to carry out their daily activities. The two primary types of mood disorders are depressive disorders (such as major depressive disorder or persistent depressive disorder) and bipolar disorders (which include bipolar I disorder, bipolar II disorder, and cyclothymic disorder).

Depressive disorders involve prolonged periods of low mood, sadness, hopelessness, and a lack of interest in activities. Individuals with these disorders may also experience changes in sleep patterns, appetite, energy levels, concentration, and self-esteem. In severe cases, they might have thoughts of death or suicide.

Bipolar disorders involve alternating episodes of mania (or hypomania) and depression. During a manic episode, individuals may feel extremely elated, energetic, or irritable, with racing thoughts, rapid speech, and impulsive behavior. They might engage in risky activities, have decreased sleep needs, and display poor judgment. In contrast, depressive episodes involve the same symptoms as depressive disorders.

Mood disorders can be caused by a combination of genetic, biological, environmental, and psychological factors. Proper diagnosis and treatment, which may include psychotherapy, medication, or a combination of both, are essential for managing these conditions and improving quality of life.

"Motor activity" is a general term used in the field of medicine and neuroscience to refer to any kind of physical movement or action that is generated by the body's motor system. The motor system includes the brain, spinal cord, nerves, and muscles that work together to produce movements such as walking, talking, reaching for an object, or even subtle actions like moving your eyes.

Motor activity can be voluntary, meaning it is initiated intentionally by the individual, or involuntary, meaning it is triggered automatically by the nervous system without conscious control. Examples of voluntary motor activity include deliberately lifting your arm or kicking a ball, while examples of involuntary motor activity include heartbeat, digestion, and reflex actions like jerking your hand away from a hot stove.

Abnormalities in motor activity can be a sign of neurological or muscular disorders, such as Parkinson's disease, cerebral palsy, or multiple sclerosis. Assessment of motor activity is often used in the diagnosis and treatment of these conditions.

A geriatric assessment is a comprehensive, multidimensional evaluation of an older adult's functional ability, mental health, social support, and overall health status. It is used to identify any medical, psychological, or social problems that could affect the person's ability to live independently and safely, and to develop an individualized plan of care to address those issues.

The assessment typically includes a review of the person's medical history, medications, cognitive function, mobility, sensory function, nutrition, continence, and mood. It may also include assessments of the person's social support network, living situation, and financial resources. The goal of the geriatric assessment is to help older adults maintain their independence and quality of life for as long as possible by addressing any issues that could put them at risk for disability or institutionalization.

Lewy body disease, also known as dementia with Lewy bodies, is a type of progressive degenerative dementia that affects thinking, behavior, and movement. It's named after Dr. Friedrich Lewy, the scientist who discovered the abnormal protein deposits, called Lewy bodies, that are characteristic of this disease.

Lewy bodies are made up of a protein called alpha-synuclein and are found in the brain cells of individuals with Lewy body disease. These abnormal protein deposits are also found in people with Parkinson's disease, but they are more widespread in Lewy body disease, affecting multiple areas of the brain.

The symptoms of Lewy body disease can vary from person to person, but they often include:

* Cognitive decline, such as memory loss, confusion, and difficulty with problem-solving
* Visual hallucinations and delusions
* Parkinsonian symptoms, such as stiffness, tremors, and difficulty walking or moving
* Fluctuations in alertness and attention
* REM sleep behavior disorder, where a person acts out their dreams during sleep

Lewy body disease is a progressive condition, which means that the symptoms get worse over time. Currently, there is no cure for Lewy body disease, but medications can help manage some of the symptoms.

Anxiety disorders are a category of mental health disorders characterized by feelings of excessive and persistent worry, fear, or anxiety that interfere with daily activities. They include several different types of disorders, such as:

1. Generalized Anxiety Disorder (GAD): This is characterized by chronic and exaggerated worry and tension, even when there is little or nothing to provoke it.
2. Panic Disorder: This is characterized by recurring unexpected panic attacks and fear of experiencing more panic attacks.
3. Social Anxiety Disorder (SAD): Also known as social phobia, this is characterized by excessive fear, anxiety, or avoidance of social situations due to feelings of embarrassment, self-consciousness, and concern about being judged or viewed negatively by others.
4. Phobias: These are intense, irrational fears of certain objects, places, or situations. When a person with a phobia encounters the object or situation they fear, they may experience panic attacks or other severe anxiety responses.
5. Agoraphobia: This is a fear of being in places where it may be difficult to escape or get help if one has a panic attack or other embarrassing or incapacitating symptoms.
6. Separation Anxiety Disorder (SAD): This is characterized by excessive anxiety about separation from home or from people to whom the individual has a strong emotional attachment (such as a parent, sibling, or partner).
7. Selective Mutism: This is a disorder where a child becomes mute in certain situations, such as at school, but can speak normally at home or with close family members.

These disorders are treatable with a combination of medication and psychotherapy (cognitive-behavioral therapy, exposure therapy). It's important to seek professional help if you suspect that you or someone you know may have an anxiety disorder.

Apolipoprotein E (APOE) is a gene that provides instructions for making a protein involved in the metabolism of fats called lipids. One variant of this gene, APOE4, is associated with an increased risk of developing Alzheimer's disease and other forms of dementia.

The APOE4 allele (variant) is less efficient at clearing beta-amyloid protein, a component of the amyloid plaques found in the brains of people with Alzheimer's disease. This can lead to an accumulation of beta-amyloid and an increased risk of developing Alzheimer's disease.

It is important to note that having one or two copies of the APOE4 allele does not mean that a person will definitely develop Alzheimer's disease, but it does increase the risk. Other factors, such as age, family history, and the presence of other genetic variants, also contribute to the development of this complex disorder.

AIDS Dementia Complex (ADC) is a neurological disorder that occurs in people with advanced HIV infection or AIDS. It is also known as HIV-associated dementia (HAD) or HIV encephalopathy. ADC is characterized by cognitive impairment, motor dysfunction, and behavioral changes that can significantly affect the individual's daily functioning and quality of life.

The symptoms of AIDS Dementia Complex may include:
- Difficulty with concentration and memory
- Slowness in thinking, processing information, or making decisions
- Changes in mood or personality, such as depression, irritability, or apathy
- Difficulty with coordination, balance, or speech
- Progressive weakness and wasting of muscles
- Difficulty with swallowing or speaking

The exact cause of ADC is not fully understood, but it is believed to be related to the direct effects of HIV on the brain. The virus can infect and damage nerve cells, leading to inflammation and degeneration of brain tissue. Treatment for ADC typically involves antiretroviral therapy (ART) to control HIV replication, as well as medications to manage specific symptoms. In some cases, supportive care such as physical therapy or occupational therapy may also be recommended.

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

Psychomotor agitation is a state of increased physical activity and purposeless or semi-purposeful voluntary movements, usually associated with restlessness, irritability, and cognitive impairment. It can be a manifestation of various medical and neurological conditions such as delirium, dementia, bipolar disorder, schizophrenia, and substance withdrawal. Psychomotor agitation may also increase the risk of aggressive behavior and physical harm to oneself or others. Appropriate evaluation and management are necessary to address the underlying cause and alleviate symptoms.

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is a publication of the American Psychiatric Association (APA) that provides diagnostic criteria for mental disorders. It is widely used by mental health professionals in the United States and around the world to diagnose and classify mental health conditions.

The DSM includes detailed descriptions of symptoms, clinical examples, and specific criteria for each disorder, which are intended to facilitate accurate diagnosis and improve communication among mental health professionals. The manual is regularly updated to reflect current research and clinical practice, with the most recent edition being the DSM-5, published in 2013.

It's important to note that while the DSM is a valuable tool for mental health professionals, it is not without controversy. Some critics argue that the manual medicalizes normal human experiences and that its categories may be too broad or overlapping. Nonetheless, it remains an essential resource for clinicians, researchers, and policymakers in the field of mental health.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Confusion is a state of bewilderment or disorientation in which a person has difficulty processing information, understanding their surroundings, and making clear decisions. It can be caused by various medical conditions such as infections, brain injury, stroke, dementia, alcohol or drug intoxication or withdrawal, and certain medications. Confusion can also occur in older adults due to age-related changes in the brain.

In medical terms, confusion is often referred to as "acute confusional state" or "delirium." It is characterized by symptoms such as difficulty paying attention, memory loss, disorientation, hallucinations, and delusions. Confusion can be a serious medical condition that requires immediate evaluation and treatment by a healthcare professional.

The Medical Definition of 'Mental Status Schedule' is:

A standardized interview and examination tool used by mental health professionals to assess an individual's cognitive, behavioral, and emotional status. The schedule typically covers areas such as orientation, attention, memory, language, visuospatial abilities, executive functions, and mood and affect. It is often used in research, clinical settings, and epidemiological studies to evaluate psychiatric and neurological conditions, as well as the effects of treatments or interventions. The specific version of the Mental Status Schedule may vary, but it generally includes a structured format with clear questions and response options to ensure standardization and reliability in the assessment process.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

A Word Association Test is not a medical term per se, but it is a psychological and neuropsychological testing procedure. It is used to assess various aspects of cognitive functioning, particularly language, memory, and executive functions. In this test, the examiner provides a word, and the person being tested is asked to quickly respond with the first word that comes to mind. The responses are then analyzed for any patterns or inconsistencies, which can provide insights into the person's cognitive processes and psychological state.

Word Association Tests have been used in various forms and contexts, including clinical evaluations, research settings, and even in some employment screenings. They can help identify language disorders, memory impairments, thought disorders, and other cognitive or emotional disturbances. However, it's important to note that these tests should be administered and interpreted by trained professionals, as they require a solid understanding of the underlying psychological principles and potential confounding factors.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Longitudinal studies are a type of research design where data is collected from the same subjects repeatedly over a period of time, often years or even decades. These studies are used to establish patterns of changes and events over time, and can help researchers identify causal relationships between variables. They are particularly useful in fields such as epidemiology, psychology, and sociology, where the focus is on understanding developmental trends and the long-term effects of various factors on health and behavior.

In medical research, longitudinal studies can be used to track the progression of diseases over time, identify risk factors for certain conditions, and evaluate the effectiveness of treatments or interventions. For example, a longitudinal study might follow a group of individuals over several decades to assess their exposure to certain environmental factors and their subsequent development of chronic diseases such as cancer or heart disease. By comparing data collected at multiple time points, researchers can identify trends and correlations that may not be apparent in shorter-term studies.

Longitudinal studies have several advantages over other research designs, including their ability to establish temporal relationships between variables, track changes over time, and reduce the impact of confounding factors. However, they also have some limitations, such as the potential for attrition (loss of participants over time), which can introduce bias and affect the validity of the results. Additionally, longitudinal studies can be expensive and time-consuming to conduct, requiring significant resources and a long-term commitment from both researchers and study participants.

Hypnotics and sedatives are classes of medications that have depressant effects on the central nervous system, leading to sedation (calming or inducing sleep), reduction in anxiety, and in some cases, decreased awareness or memory. These agents work by affecting the neurotransmitter GABA (gamma-aminobutyric acid) in the brain, which results in inhibitory effects on neuronal activity.

Hypnotics are primarily used for the treatment of insomnia and other sleep disorders, while sedatives are often prescribed to manage anxiety or to produce a calming effect before medical procedures. Some medications can function as both hypnotics and sedatives, depending on the dosage and specific formulation. Common examples of these medications include benzodiazepines (such as diazepam and lorazepam), non-benzodiazepine hypnotics (such as zolpidem and eszopiclone), barbiturates, and certain antihistamines.

It is essential to use these medications under the guidance of a healthcare professional, as they can have potential side effects, such as drowsiness, dizziness, confusion, and impaired coordination. Additionally, long-term use or high doses may lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.

Executive function is a term used to describe a set of cognitive processes that are necessary for the control and regulation of thought and behavior. These functions include:

1. Working memory: The ability to hold and manipulate information in mind over short periods of time.
2. Cognitive flexibility: The ability to switch between tasks or mental sets, and to adapt to new rules and situations.
3. Inhibitory control: The ability to inhibit or delay automatic responses, and to resist impulses and distractions.
4. Planning and organization: The ability to plan and organize actions, and to manage time and resources effectively.
5. Problem-solving: The ability to analyze problems, generate solutions, and evaluate the outcomes of actions.
6. Decision-making: The ability to weigh risks and benefits, and to make informed choices based on available information.
7. Emotional regulation: The ability to manage and regulate emotions, and to respond appropriately to social cues and situations.

Executive functions are primarily controlled by the frontal lobes of the brain, and they play a critical role in goal-directed behavior, problem-solving, decision-making, and self-regulation. Deficits in executive function can have significant impacts on daily life, including difficulties with academic performance, work productivity, social relationships, and mental health.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

An Intensive Care Unit (ICU) is a specialized hospital department that provides continuous monitoring and advanced life support for critically ill patients. The ICU is equipped with sophisticated technology and staffed by highly trained healthcare professionals, including intensivists, nurses, respiratory therapists, and other specialists.

Patients in the ICU may require mechanical ventilation, invasive monitoring, vasoactive medications, and other advanced interventions due to conditions such as severe infections, trauma, cardiac arrest, respiratory failure, or post-surgical complications. The goal of the ICU is to stabilize patients' condition, prevent further complications, and support organ function while the underlying illness is treated.

ICUs may be organized into different units based on the type of care provided, such as medical, surgical, cardiac, neurological, or pediatric ICUs. The length of stay in the ICU can vary widely depending on the patient's condition and response to treatment.

Primary Progressive Aphasia (PPA) is a neurological disorder characterized by progressive loss of language capabilities, while other cognitive abilities remain preserved. It is a type of dementia that primarily affects speech and language. Unlike other forms of aphasia that result from stroke or head injury, PPA is degenerative and gets worse over time.

There are three main types of PPA:

1. Semantic Variant PPA (svPPA): This type is characterized by difficulty in understanding words and objects, despite having no trouble with the mechanics of speech or writing. Over time, people with svPPA may lose their ability to understand spoken or written language, as well as to recognize objects and faces.

2. Nonfluent/Agrammatic Variant PPA (nfvPPA): This type is characterized by difficulty with speaking and writing, including producing grammatical sentences and articulating words. People with nfvPPA may also have problems with understanding spoken language, particularly when it comes to complex sentences or ambiguous phrases.

3. Logopenic Variant PPA (lvPPA): This type is characterized by difficulty with word-finding and sentence repetition, while speech remains fluent. People with lvPPA may also have problems with understanding spoken language, particularly when it comes to complex sentences or ambiguous phrases.

The exact cause of PPA is not known, but it is believed to be related to degeneration of specific areas of the brain involved in language processing, such as Broca's area and Wernicke's area. There is currently no cure for PPA, but speech and language therapy can help to slow down the progression of the disorder and improve communication skills.

The temporal lobe is one of the four main lobes of the cerebral cortex in the brain, located on each side of the head roughly level with the ears. It plays a major role in auditory processing, memory, and emotion. The temporal lobe contains several key structures including the primary auditory cortex, which is responsible for analyzing sounds, and the hippocampus, which is crucial for forming new memories. Damage to the temporal lobe can result in various neurological symptoms such as hearing loss, memory impairment, and changes in emotional behavior.

"Mental recall," also known as "memory recall," refers to the ability to retrieve or bring information from your memory storage into your conscious mind, so you can think about, use, or apply it. This process involves accessing and retrieving stored memories in response to certain cues or prompts. It is a fundamental cognitive function that allows individuals to remember and recognize people, places, events, facts, and experiences.

In the context of medical terminology, mental recall may be used to assess an individual's cognitive abilities, particularly in relation to memory function. Impairments in memory recall can be indicative of various neurological or psychological conditions, such as dementia, Alzheimer's disease, or amnesia.

A caregiver is an individual who provides assistance and support to another person who is unable to meet their own needs for activities of daily living due to illness, disability, frailty, or other reasons. Caregiving can take many forms, including providing physical care, emotional support, managing medications, assisting with mobility, and helping with household tasks and errands. Caregivers may be family members, friends, or professional providers, and the level of care they provide can range from a few hours a week to round-the-clock assistance. In medical contexts, caregivers are often referred to as informal or family caregivers when they are unpaid relatives or friends, and professional or paid caregivers when they are hired to provide care.

Major Depressive Disorder (MDD), also simply referred to as depression, is a serious mental health condition characterized by the presence of one or more major depressive episodes. A major depressive episode is a period of at least two weeks during which an individual experiences a severely depressed mood and/or loss of interest or pleasure in nearly all activities, accompanied by at least four additional symptoms such as significant changes in appetite or weight, sleep disturbances, psychomotor agitation or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, difficulty thinking, concentrating, or making decisions, and recurrent thoughts of death or suicide.

MDD can significantly impair an individual's ability to function in daily life, and it is associated with increased risks of suicide, substance abuse, and other mental health disorders. The exact cause of MDD is not fully understood, but it is believed to result from a complex interplay of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of psychotherapy (such as cognitive-behavioral therapy) and medication (such as selective serotonin reuptake inhibitors or tricyclic antidepressants).

Tau proteins are a type of microtubule-associated protein (MAP) found primarily in neurons of the central nervous system. They play a crucial role in maintaining the stability and structure of microtubules, which are essential components of the cell's cytoskeleton. Tau proteins bind to and stabilize microtubules, helping to regulate their assembly and disassembly.

In Alzheimer's disease and other neurodegenerative disorders known as tauopathies, tau proteins can become abnormally hyperphosphorylated, leading to the formation of insoluble aggregates called neurofibrillary tangles (NFTs) within neurons. These aggregates disrupt the normal function of microtubules and contribute to the degeneration and death of nerve cells, ultimately leading to cognitive decline and other symptoms associated with these disorders.

Cholinesterase inhibitors are a class of drugs that work by blocking the action of cholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine in the body. By inhibiting this enzyme, the levels of acetylcholine in the brain increase, which can help to improve symptoms of cognitive decline and memory loss associated with conditions such as Alzheimer's disease and other forms of dementia.

Cholinesterase inhibitors are also used to treat other medical conditions, including myasthenia gravis, a neuromuscular disorder that causes muscle weakness, and glaucoma, a condition that affects the optic nerve and can lead to vision loss. Some examples of cholinesterase inhibitors include donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon).

It's important to note that while cholinesterase inhibitors can help to improve symptoms in some people with dementia, they do not cure the underlying condition or stop its progression. Side effects of these drugs may include nausea, vomiting, diarrhea, and increased salivation. In rare cases, they may also cause seizures, fainting, or cardiac arrhythmias.

A depressive disorder is a mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest or pleasure in activities. It can also include changes in sleep, appetite, energy levels, concentration, and self-esteem, as well as thoughts of death or suicide. Depressive disorders can vary in severity and duration, with some people experiencing mild and occasional symptoms, while others may have severe and chronic symptoms that interfere with their ability to function in daily life.

There are several types of depressive disorders, including major depressive disorder (MDD), persistent depressive disorder (PDD), and postpartum depression. MDD is characterized by symptoms that interfere significantly with a person's ability to function and last for at least two weeks, while PDD involves chronic low-grade depression that lasts for two years or more. Postpartum depression occurs in women after childbirth and can range from mild to severe.

Depressive disorders are thought to be caused by a combination of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of medication, psychotherapy (talk therapy), and lifestyle changes.

Computer-assisted image processing is a medical term that refers to the use of computer systems and specialized software to improve, analyze, and interpret medical images obtained through various imaging techniques such as X-ray, CT (computed tomography), MRI (magnetic resonance imaging), ultrasound, and others.

The process typically involves several steps, including image acquisition, enhancement, segmentation, restoration, and analysis. Image processing algorithms can be used to enhance the quality of medical images by adjusting contrast, brightness, and sharpness, as well as removing noise and artifacts that may interfere with accurate diagnosis. Segmentation techniques can be used to isolate specific regions or structures of interest within an image, allowing for more detailed analysis.

Computer-assisted image processing has numerous applications in medical imaging, including detection and characterization of lesions, tumors, and other abnormalities; assessment of organ function and morphology; and guidance of interventional procedures such as biopsies and surgeries. By automating and standardizing image analysis tasks, computer-assisted image processing can help to improve diagnostic accuracy, efficiency, and consistency, while reducing the potential for human error.

A nursing home, also known as a skilled nursing facility, is a type of residential healthcare facility that provides round-the-clock care and assistance to individuals who require a high level of medical care and support with activities of daily living. Nursing homes are designed for people who cannot be cared for at home or in an assisted living facility due to their complex medical needs, mobility limitations, or cognitive impairments.

Nursing homes provide a range of services, including:

1. Skilled nursing care: Registered nurses and licensed practical nurses provide 24-hour medical care and monitoring for residents with chronic illnesses, disabilities, or those recovering from surgery or illness.
2. Rehabilitation services: Physical, occupational, and speech therapists help residents regain strength, mobility, and communication skills after an injury, illness, or surgery.
3. Personal care: Certified nursing assistants (CNAs) help residents with activities of daily living, such as bathing, dressing, grooming, and using the bathroom.
4. Meals and nutrition: Nursing homes provide three meals a day, plus snacks, and accommodate special dietary needs.
5. Social activities: Recreational programs and social events are organized to help residents stay active and engaged with their peers.
6. Hospice care: Some nursing homes offer end-of-life care for residents who require palliative or comfort measures.
7. Secure environments: For residents with memory impairments, specialized units called memory care or Alzheimer's units provide a secure and structured environment to help maintain their safety and well-being.

When selecting a nursing home, it is essential to consider factors such as the quality of care, staff-to-resident ratio, cleanliness, and overall atmosphere to ensure the best possible experience for the resident.

The Trail Making Test (TMT) is a neuropsychological test that is used to assess a person's ability to visually scan, sequence, and connect numbers and letters. It consists of two parts: Part A and Part B.

Part A requires the individual to draw lines connecting numbers in sequential order (e.g., 1-2-3-4) as quickly and accurately as possible. This part of the test measures processing speed, visual search, and motor functioning.

Part B is more complex, requiring the individual to alternate between connecting numbers and letters in sequential order (e.g., 1-A-2-B-3-C). Part B assesses higher-level cognitive abilities such as mental flexibility, working memory, and executive function.

The TMT is often used in clinical settings to help diagnose neurological conditions such as Alzheimer's disease, Parkinson's disease, traumatic brain injury, and attention deficit hyperactivity disorder (ADHD). It can also be used to assess the effectiveness of treatment interventions. The test results are typically reported in terms of time taken to complete each part, with longer times indicating greater cognitive impairment.

I believe there may be a slight confusion in your question as hypnosis and anesthesia are two different concepts in the field of medicine. Here are separate definitions for each:

1. Hypnosis: This is a state of highly focused attention or concentration, often associated with relaxation, and heightened suggestibility. During hypnosis, a person may become more open to suggestions and their perception of reality may change. It's important to note that hypnosis is not a form of unconsciousness or sleep, and the person can usually hear and remember what happens during the session. Hypnosis is sometimes used in medical and psychological settings to help manage pain, anxiety, or symptoms of various conditions.

2. Anesthetic: An anesthetic is a drug that's used to block sensation in certain areas of the body or to induce sleep and reduce pain during surgical procedures. There are two main types of anesthetics: local and general. Local anesthetics numb a specific area of the body, while general anesthetics cause a state of unconsciousness and amnesia, so the person is unaware of the procedure taking place. Anesthetics work by depressing the function of the central nervous system, which includes the brain and spinal cord.

I hope this clarifies any confusion! If you have any further questions or need more information, please don't hesitate to ask.

Brain mapping is a broad term that refers to the techniques used to understand the structure and function of the brain. It involves creating maps of the various cognitive, emotional, and behavioral processes in the brain by correlating these processes with physical locations or activities within the nervous system. Brain mapping can be accomplished through a variety of methods, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET) scans, electroencephalography (EEG), and others. These techniques allow researchers to observe which areas of the brain are active during different tasks or thoughts, helping to shed light on how the brain processes information and contributes to our experiences and behaviors. Brain mapping is an important area of research in neuroscience, with potential applications in the diagnosis and treatment of neurological and psychiatric disorders.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Activities of Daily Living (ADL) are routine self-care activities that individuals usually do every day without assistance. These activities are widely used as a measure to determine the functional status and independence of a person, particularly in the elderly or those with disabilities or chronic illnesses. The basic ADLs include:

1. Personal hygiene: Bathing, washing hands and face, brushing teeth, grooming, and using the toilet.
2. Dressing: Selecting appropriate clothes and dressing oneself.
3. Eating: Preparing and consuming food, either independently or with assistive devices.
4. Mobility: Moving in and out of bed, chairs, or wheelchairs, walking independently or using mobility aids.
5. Transferring: Moving from one place to another, such as getting in and out of a car, bath, or bed.

There are also more complex Instrumental Activities of Daily Living (IADLs) that assess an individual's ability to manage their own life and live independently. These include managing finances, shopping for groceries, using the telephone, taking medications as prescribed, preparing meals, and housekeeping tasks.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Anterograde amnesia is a specific type of memory loss where a person has difficulty forming new memories or learning and retaining new information after the onset of the amnesia. It is often caused by damage to certain parts of the brain, such as the hippocampus and surrounding structures, which play a crucial role in the formation of new memories.

In anterograde amnesia, people may have trouble remembering events that occurred after the onset of their memory impairment, while their ability to recall remote memories or those that were formed before the onset of the amnesia is typically preserved. The severity of anterograde amnesia can vary widely, from mild difficulty with learning new information to a complete inability to form any new memories.

Anterograde amnesia can be caused by various factors, including brain injury, infection, stroke, alcohol or drug abuse, seizures, and certain medical conditions such as Wernicke-Korsakoff syndrome, which is often associated with chronic alcoholism. Treatment for anterograde amnesia depends on the underlying cause and may involve medication, rehabilitation, or other interventions to help improve memory function.

Attention Deficit Hyperactivity Disorder (ADHD) with hyperactivity is a neurodevelopmental disorder that affects both children and adults. The condition is characterized by symptoms including:

1. Difficulty paying attention or staying focused on a single task
2. Impulsivity, or acting without thinking
3. Hyperactivity, or excessive fidgeting, restlessness, or talking

In order to be diagnosed with ADHD with hyperactivity, an individual must exhibit these symptoms to a degree that is developmentally inappropriate and interferes with their daily functioning. Additionally, the symptoms must have been present for at least six months and be present in multiple settings (e.g., at home, school, work).

It's important to note that ADHD can manifest differently in different people, and some individuals may experience predominantly inattentive or impulsive symptoms rather than hyperactive ones. However, when the hyperactive component is prominent, it is referred to as ADHD with hyperactivity.

Effective treatments for ADHD with hyperactivity include a combination of medication (such as stimulants) and behavioral therapy. With appropriate treatment, individuals with ADHD can learn to manage their symptoms and lead successful, fulfilling lives.

Amyloid beta-peptides (Aβ) are small protein fragments that are crucially involved in the pathogenesis of Alzheimer's disease. They are derived from a larger transmembrane protein called the amyloid precursor protein (APP) through a series of proteolytic cleavage events.

The two primary forms of Aβ peptides are Aβ40 and Aβ42, which differ in length by two amino acids. While both forms can be harmful, Aβ42 is more prone to aggregation and is considered to be the more pathogenic form. These peptides have the tendency to misfold and accumulate into oligomers, fibrils, and eventually insoluble plaques that deposit in various areas of the brain, most notably the cerebral cortex and hippocampus.

The accumulation of Aβ peptides is believed to initiate a cascade of events leading to neuroinflammation, oxidative stress, synaptic dysfunction, and neuronal death, which are all hallmarks of Alzheimer's disease. Although the exact role of Aβ in the onset and progression of Alzheimer's is still under investigation, it is widely accepted that they play a central part in the development of this debilitating neurodegenerative disorder.

Haloperidol is an antipsychotic medication, which is primarily used to treat schizophrenia and symptoms of psychosis, such as delusions, hallucinations, paranoia, or disordered thought. It may also be used to manage Tourette's disorder, tics, agitation, aggression, and hyperactivity in children with developmental disorders.

Haloperidol works by blocking the action of dopamine, a neurotransmitter in the brain, which helps to regulate mood and behavior. It is available in various forms, including tablets, liquid, and injectable solutions. The medication can cause side effects such as drowsiness, restlessness, muscle stiffness, and uncontrolled movements. In rare cases, it may also lead to more serious neurological side effects.

As with any medication, haloperidol should be taken under the supervision of a healthcare provider, who will consider the individual's medical history, current medications, and other factors before prescribing it.

'Institutionalization' in a medical context refers to the process or state of becoming accustomed to or dependent on a institution, such as a hospital or long-term care facility, for one's care and living arrangements. This can occur over time as an individual becomes more reliant on the services and structure provided by the institution. It can also refer to the social and psychological effects that may result from living in an institutional setting for a long period of time, which can include decreased initiative, dependency, and difficulty functioning in a less structured environment. Institutionalization can have negative impacts on an individual's quality of life and overall well-being, and efforts are often made to help individuals maintain their independence and community connections whenever possible.

"Indans" is not a recognized medical term or abbreviation in the field of medicine or pharmacology. It's possible that you may be referring to "indanes," which are chemical compounds that contain a indane ring structure, consisting of two benzene rings fused in an angular arrangement. Some indane derivatives have been studied for their potential medicinal properties, such as anti-inflammatory and analgesic effects. However, it's important to note that the medical use and efficacy of these compounds can vary widely and should be evaluated on a case-by-case basis under the guidance of a qualified healthcare professional.

Antipsychotic agents are a class of medications used to manage and treat psychosis, which includes symptoms such as delusions, hallucinations, paranoia, disordered thought processes, and agitated behavior. These drugs work by blocking the action of dopamine, a neurotransmitter in the brain that is believed to play a role in the development of psychotic symptoms. Antipsychotics can be broadly divided into two categories: first-generation antipsychotics (also known as typical antipsychotics) and second-generation antipsychotics (also known as atypical antipsychotics).

First-generation antipsychotics, such as chlorpromazine, haloperidol, and fluphenazine, were developed in the 1950s and have been widely used for several decades. They are generally effective in reducing positive symptoms of psychosis (such as hallucinations and delusions) but can cause significant side effects, including extrapyramidal symptoms (EPS), such as rigidity, tremors, and involuntary movements, as well as weight gain, sedation, and orthostatic hypotension.

Second-generation antipsychotics, such as clozapine, risperidone, olanzapine, quetiapine, and aripiprazole, were developed more recently and are considered to have a more favorable side effect profile than first-generation antipsychotics. They are generally effective in reducing both positive and negative symptoms of psychosis (such as apathy, anhedonia, and social withdrawal) and cause fewer EPS. However, they can still cause significant weight gain, metabolic disturbances, and sedation.

Antipsychotic agents are used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder with psychotic features, delusional disorder, and other conditions that involve psychosis or agitation. They can be administered orally, intramuscularly, or via long-acting injectable formulations. The choice of antipsychotic agent depends on the individual patient's needs, preferences, and response to treatment, as well as the potential for side effects. Regular monitoring of patients taking antipsychotics is essential to ensure their safety and effectiveness.

Episodic memory is a type of declarative (explicit) memory that involves the ability to recall and mentally reexperience specific events or episodes, including their temporal and spatial contexts. It is the memory for particular events or episodes that are embedded in a personal autobiographical timeline, along with the details of what happened, where it happened, who was involved, and when it happened. Episodic memories are often formed through conscious effort and can be voluntarily retrieved. They are susceptible to interference and decay over time, making them less reliable than other types of memory.

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

A Nursing Diagnosis is a clinical judgment about an individual's response to actual or potential health conditions. It is the foundation for selecting nursing interventions and expected outcomes, and it is based on assessment data, nursing knowledge, and clinical reasoning. The North American Nursing Diagnosis Association (NANDA) provides standardized nursing diagnoses that are classified into 13 domains, such as nutrition, elimination, breathing, and comfort.

The purpose of a nursing diagnosis is to identify the patient's problems or needs that can be addressed through nursing interventions. It helps nurses to communicate effectively with other healthcare professionals about the patient's condition, plan care, evaluate outcomes, and make decisions about the most appropriate interventions. The nursing diagnosis should be individualized to each patient based on their unique needs, values, and preferences.

Examples of nursing diagnoses include "Risk for Infection," "Impaired Gas Exchange," "Ineffective Coping," "Activity Intolerance," and "Pain." Each nursing diagnosis has defining characteristics, related factors, and risk factors that help nurses to identify and document the diagnosis accurately. The use of standardized nursing diagnoses also enables researchers to evaluate the effectiveness of nursing interventions and contribute to evidence-based practice.

Verbal learning is a type of learning that involves the acquisition, processing, and retrieval of information presented in a verbal or written form. It is often assessed through tasks such as list learning, where an individual is asked to remember a list of words or sentences after a single presentation or multiple repetitions. Verbal learning is an important aspect of cognitive functioning and is commonly evaluated in neuropsychological assessments to help identify any memory or learning impairments.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

A nursing assessment is the process of collecting and analyzing data about a patient's health status, including their physical, psychological, social, cultural, and emotional needs. This information is used to identify actual or potential health problems, develop a plan of care, and evaluate the effectiveness of interventions. Nursing assessments may include observing and documenting the patient's vital signs, appearance, behavior, mobility, nutrition, elimination, comfort level, cognitive status, and emotional well-being. They are typically conducted upon admission to a healthcare facility, during transitions of care, and on a regular basis throughout the course of treatment to ensure that the patient's needs are being met and that any changes in their condition are promptly identified and addressed.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

A critical illness is a serious condition that has the potential to cause long-term or permanent disability, or even death. It often requires intensive care and life support from medical professionals. Critical illnesses can include conditions such as:

1. Heart attack
2. Stroke
3. Organ failure (such as kidney, liver, or lung)
4. Severe infections (such as sepsis)
5. Coma or brain injury
6. Major trauma
7. Cancer that has spread to other parts of the body

These conditions can cause significant physical and emotional stress on patients and their families, and often require extensive medical treatment, rehabilitation, and long-term care. Critical illness insurance is a type of insurance policy that provides financial benefits to help cover the costs associated with treating these serious medical conditions.

Psychotic disorders are a group of severe mental health conditions characterized by distorted perceptions, thoughts, and emotions that lead to an inability to recognize reality. The two most common symptoms of psychotic disorders are hallucinations and delusions. Hallucinations are when a person sees, hears, or feels things that aren't there, while delusions are fixed, false beliefs that are not based on reality.

Other symptoms may include disorganized speech, disorganized behavior, catatonic behavior, and negative symptoms such as apathy and lack of emotional expression. Schizophrenia is the most well-known psychotic disorder, but other types include schizoaffective disorder, delusional disorder, brief psychotic disorder, shared psychotic disorder, and substance-induced psychotic disorder.

Psychotic disorders can be caused by a variety of factors, including genetics, brain chemistry imbalances, trauma, and substance abuse. Treatment typically involves a combination of medication, therapy, and support services to help manage symptoms and improve quality of life.

Benzodiazepines are a class of psychoactive drugs that have been widely used for their sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. They act by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system.

Benzodiazepines are commonly prescribed for the treatment of anxiety disorders, insomnia, seizures, and muscle spasms. They can also be used as premedication before medical procedures to produce sedation, amnesia, and anxiolysis. Some examples of benzodiazepines include diazepam (Valium), alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and temazepam (Restoril).

While benzodiazepines are effective in treating various medical conditions, they can also cause physical dependence and withdrawal symptoms. Long-term use of benzodiazepines can lead to tolerance, meaning that higher doses are needed to achieve the same effect. Abrupt discontinuation of benzodiazepines can result in severe withdrawal symptoms, including seizures, hallucinations, and anxiety. Therefore, it is important to taper off benzodiazepines gradually under medical supervision.

Benzodiazepines are classified as Schedule IV controlled substances in the United States due to their potential for abuse and dependence. It is essential to use them only as directed by a healthcare provider and to be aware of their potential risks and benefits.

Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by the presence of obsessions and compulsions. Obsessions are recurrent and persistent thoughts, urges, or images that are intrusive, unwanted, and often distressing. Compulsions are repetitive behaviors or mental acts that an individual feels driven to perform in response to an obsession or according to rigid rules, and which are aimed at preventing or reducing anxiety or distress, or preventing some dreaded event or situation. These obsessions and/or compulsions cause significant distress, take up a lot of time (an hour or more a day), and interfere with the individual's daily life, including social activities, relationships, and work or school performance. OCD is considered a type of anxiety disorder and can also co-occur with other mental health conditions.

Post-traumatic stress disorder (PTSD) is a psychiatric condition that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, serious accident, war combat, rape, or violent personal assault. According to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), PTSD is characterized by the following symptoms, which must last for more than one month:

1. Intrusion symptoms: These include distressing memories, nightmares, flashbacks, or intense psychological distress or reactivity to internal or external cues that symbolize or resemble an aspect of the traumatic event.
2. Avoidance symptoms: Persistent avoidance of stimuli associated with the traumatic event, including thoughts, feelings, conversations, activities, places, or people.
3. Negative alterations in cognitions and mood: This includes negative beliefs about oneself, others, or the world; distorted blame of self or others for causing the trauma; persistent negative emotional state; decreased interest in significant activities; and feelings of detachment or estrangement from others.
4. Alterations in arousal and reactivity: This includes irritable behavior and angry outbursts, reckless or self-destructive behavior, hypervigilance, exaggerated startle response, problems with concentration, and sleep disturbance.
5. Duration of symptoms: The symptoms must last for more than one month.
6. Functional significance: The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

It is essential to note that PTSD can occur at any age and can be accompanied by various physical and mental health problems, such as depression, substance abuse, memory problems, and other difficulties in cognition. Appropriate treatment, which may include psychotherapy, medication, or a combination of both, can significantly improve the symptoms and overall quality of life for individuals with PTSD.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Autistic Disorder, also known as Autism or Classic Autism, is a neurodevelopmental disorder that affects communication and behavior. It is characterized by:

1. Persistent deficits in social communication and social interaction across multiple contexts, including:
* Deficits in social-emotional reciprocity;
* Deficits in nonverbal communicative behaviors used for social interaction;
* Deficits in developing, maintaining, and understanding relationships.
2. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least two of the following:
* Stereotyped or repetitive motor movements, use of objects, or speech;
* Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal behavior;
* Highly restricted, fixated interests that are abnormal in intensity or focus;
* Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment.
3. Symptoms must be present in the early developmental period (but may not become fully manifest until social demands exceed limited capacities) and limit or impair everyday functioning.
4. Symptoms do not occur exclusively during the course of a schizophrenia spectrum disorder or other psychotic disorders.

Autistic Disorder is part of the autism spectrum disorders (ASDs), which also include Asperger's Syndrome and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). The current diagnostic term for this category of conditions, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is Autism Spectrum Disorder.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Postoperative complications refer to any unfavorable condition or event that occurs during the recovery period after a surgical procedure. These complications can vary in severity and may include, but are not limited to:

1. Infection: This can occur at the site of the incision or inside the body, such as pneumonia or urinary tract infection.
2. Bleeding: Excessive bleeding (hemorrhage) can lead to a drop in blood pressure and may require further surgical intervention.
3. Blood clots: These can form in the deep veins of the legs (deep vein thrombosis) and can potentially travel to the lungs (pulmonary embolism).
4. Wound dehiscence: This is when the surgical wound opens up, which can lead to infection and further complications.
5. Pulmonary issues: These include atelectasis (collapsed lung), pneumonia, or respiratory failure.
6. Cardiovascular problems: These include abnormal heart rhythms (arrhythmias), heart attack, or stroke.
7. Renal failure: This can occur due to various reasons such as dehydration, blood loss, or the use of certain medications.
8. Pain management issues: Inadequate pain control can lead to increased stress, anxiety, and decreased mobility.
9. Nausea and vomiting: These can be caused by anesthesia, opioid pain medication, or other factors.
10. Delirium: This is a state of confusion and disorientation that can occur in the elderly or those with certain medical conditions.

Prompt identification and management of these complications are crucial to ensure the best possible outcome for the patient.

Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.

Alcoholic psychosis is a term used to describe a group of psychiatric disorders that are directly related to alcohol abuse or withdrawal. The two most common types of alcoholic psychosis are Wernicke's encephalopathy and Korsakoff's syndrome, which often occur together and are referred to as Wernicke-Korsakoff syndrome.

Wernicke's encephalopathy is a acute neurological disorder characterized by confusion, memory loss, difficulty with muscle coordination, and abnormal eye movements. It is caused by a thiamine (vitamin B1) deficiency that is often seen in people who are chronic alcoholics.

Korsakoff's syndrome, on the other hand, is a chronic memory disorder characterized by severe memory loss and confusion. People with Korsakoff's syndrome often have difficulty learning new information and may confabulate, or make up information, to fill in gaps in their memory.

Both Wernicke's encephalopathy and Korsakoff's syndrome are serious conditions that require immediate medical attention. Treatment typically involves administering thiamine and other vitamins, as well as providing supportive care to help manage symptoms. In some cases, hospitalization may be necessary.

It is important to note that alcohol abuse can also lead to other types of psychosis, such as delirium tremens (DTs), which is a severe form of alcohol withdrawal that can cause confusion, hallucinations, and seizures. If you or someone you know is struggling with alcohol abuse, it is important to seek professional help as soon as possible.

I couldn't find a specific medical definition for "Homes for the Aged," as it is more commonly referred to in social work or public health contexts. However, I can provide you with some related information:

"Homes for the Aged" are typically residential facilities designed to provide housing, support services, and care for older adults, often with lower levels of medical needs compared to nursing homes. These facilities might offer assistance with activities of daily living (ADLs) such as bathing, dressing, grooming, and managing medications. They can be an alternative to aging in place or moving in with family members.

In a broader public health context, "Homes for the Aged" may fall under the category of congregate housing or assisted living facilities. These settings aim to promote social interaction, autonomy, and independence while offering help with daily tasks and ensuring the safety of their residents.

It is essential to research and visit various facilities to ensure they meet individual needs, preferences, and healthcare requirements when considering Homes for the Aged for yourself or a loved one.

A phobic disorder is a type of anxiety disorder characterized by an excessive and irrational fear or avoidance of specific objects, situations, or activities. This fear can cause significant distress and interfere with a person's daily life. Phobic disorders are typically classified into three main categories: specific phobias (such as fear of heights, spiders, or needles), social phobia (or social anxiety disorder), and agoraphobia (fear of open spaces or situations where escape might be difficult).

People with phobic disorders often recognize that their fear is excessive or unreasonable, but they are unable to control it. When exposed to the feared object or situation, they may experience symptoms such as rapid heartbeat, sweating, trembling, and difficulty breathing. These symptoms can be so distressing that individuals with phobic disorders go to great lengths to avoid the feared situation, which can have a significant impact on their quality of life.

Treatment for phobic disorders typically involves cognitive-behavioral therapy (CBT), which helps individuals identify and challenge their irrational thoughts and fears, as well as exposure therapy, which gradually exposes them to the feared object or situation in a safe and controlled environment. In some cases, medication may also be recommended to help manage symptoms of anxiety.

Substance-related disorders, as defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), refer to a group of conditions caused by the use of substances such as alcohol, drugs, or medicines. These disorders are characterized by a problematic pattern of using a substance that leads to clinically significant impairment or distress. They can be divided into two main categories: substance use disorders and substance-induced disorders. Substance use disorders involve a pattern of compulsive use despite negative consequences, while substance-induced disorders include conditions such as intoxication, withdrawal, and substance/medication-induced mental disorders. The specific diagnosis depends on the type of substance involved, the patterns of use, and the presence or absence of physiological dependence.

Pervasive developmental disorders (PDD) are a group of conditions that affect the development and functioning of the brain, leading to delays in many areas of development. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) has replaced the term "pervasive developmental disorders" with "autism spectrum disorder" and "other neurodevelopmental disorders."

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction across multiple contexts, as well as restricted, repetitive patterns of behavior, interests, or activities. The symptoms of ASD can range from mild to severe, and the condition affects approximately 1 in 54 children in the United States.

Other neurodevelopmental disorders that were previously classified as PDDs include:

1. Intellectual disability (ID): a condition characterized by significant limitations in intellectual functioning and adaptive behavior, which covers many everyday social and practical skills. This disorder used to be referred to as "mental retardation."
2. Communication disorders: these are disorders that affect an individual's ability to communicate, including language disorders, speech sound disorders, and stuttering.
3. Attention-deficit/hyperactivity disorder (ADHD): a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity.
4. Specific learning disorder: a neurodevelopmental disorder that affects an individual's ability to learn and use specific academic skills, such as reading, writing, or mathematics.
5. Motor disorders: these are disorders that affect an individual's movement and coordination, including developmental coordination disorder, stereotypic movement disorder, and tic disorders.

The medical definition of 'Child Development Disorders, Pervasive' has been replaced with more specific diagnoses in the DSM-5 to better reflect the diverse nature of these conditions and improve diagnostic accuracy and treatment planning.

Parkinson's disease is a progressive neurodegenerative disorder that affects movement. It is characterized by the death of dopamine-producing cells in the brain, specifically in an area called the substantia nigra. The loss of these cells leads to a decrease in dopamine levels, which results in the motor symptoms associated with Parkinson's disease. These symptoms can include tremors at rest, stiffness or rigidity of the limbs and trunk, bradykinesia (slowness of movement), and postural instability (impaired balance and coordination). In addition to these motor symptoms, non-motor symptoms such as cognitive impairment, depression, anxiety, and sleep disturbances are also common in people with Parkinson's disease. The exact cause of Parkinson's disease is unknown, but it is thought to be a combination of genetic and environmental factors. There is currently no cure for Parkinson's disease, but medications and therapies can help manage the symptoms and improve quality of life.

Alcohol Amnestic Disorder is not listed as a separate disorder in the current edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which is used by mental health professionals to diagnose mental conditions. However, it was previously included in earlier editions as a subtype of Amnestic Disorder due to the effects of substance use or exposure to toxins.

Alcohol Amnestic Disorder is characterized by significant memory impairment that is directly caused by alcohol consumption. This disorder can result in anterograde amnesia, which is the inability to form new memories after drinking, and/or retrograde amnesia, which involves forgetting previously learned information or personal experiences.

The diagnosis of Alcohol Amnestic Disorder typically requires a comprehensive medical and neuropsychological evaluation to determine the extent and nature of memory impairment, as well as to rule out other potential causes for cognitive decline. Treatment usually involves a combination of abstinence from alcohol, pharmacotherapy, and psychosocial interventions to address substance use disorder and any co-occurring mental health conditions.

Geriatric psychiatry is a subspecialty of psychiatry that focuses on the mental health concerns of older adults, usually defined as those aged 65 and over. This field addresses the biological and psychological changes that occur with aging, as well as the social and cultural issues that impact the mental health of this population.

The mental health conditions commonly seen in geriatric psychiatry include:

1. Dementia (such as Alzheimer's disease)
2. Depression and anxiety disorders
3. Late-life schizophrenia and other psychotic disorders
4. Substance abuse and addiction
5. Neurocognitive disorders due to medical conditions, such as Parkinson's disease or stroke
6. Sleep disturbances and insomnia
7. Delirium and other cognitive changes related to acute illness or hospitalization
8. Mental health concerns related to chronic medical conditions, such as diabetes or heart disease
9. End-of-life issues and palliative care
10. Issues related to grief, loss, and transitions in later life

Geriatric psychiatrists are trained to recognize and manage these conditions while also considering the potential impact of medications, physical health problems, sensory impairments, and social supports on mental health treatment outcomes. They often work closely with primary care physicians, neurologists, social workers, and other healthcare professionals to provide comprehensive care for older adults.

The cerebral cortex is the outermost layer of the brain, characterized by its intricate folded structure and wrinkled appearance. It is a region of great importance as it plays a key role in higher cognitive functions such as perception, consciousness, thought, memory, language, and attention. The cerebral cortex is divided into two hemispheres, each containing four lobes: the frontal, parietal, temporal, and occipital lobes. These areas are responsible for different functions, with some regions specializing in sensory processing while others are involved in motor control or associative functions. The cerebral cortex is composed of gray matter, which contains neuronal cell bodies, and is covered by a layer of white matter that consists mainly of myelinated nerve fibers.

Psychotropic drugs, also known as psychoactive drugs, are a class of medications that affect the function of the central nervous system, leading to changes in consciousness, perception, mood, cognition, or behavior. These drugs work by altering the chemical neurotransmitters in the brain, such as dopamine, serotonin, and norepinephrine, which are involved in regulating mood, thought, and behavior.

Psychotropic drugs can be classified into several categories based on their primary therapeutic effects, including:

1. Antipsychotic drugs: These medications are used to treat psychosis, schizophrenia, and other related disorders. They work by blocking dopamine receptors in the brain, which helps reduce hallucinations, delusions, and disordered thinking.
2. Antidepressant drugs: These medications are used to treat depression, anxiety disorders, and some chronic pain conditions. They work by increasing the availability of neurotransmitters such as serotonin, norepinephrine, or dopamine in the brain, which helps improve mood and reduce anxiety.
3. Mood stabilizers: These medications are used to treat bipolar disorder and other mood disorders. They help regulate the ups and downs of mood swings and can also be used as adjunctive treatment for depression and anxiety.
4. Anxiolytic drugs: Also known as anti-anxiety medications, these drugs are used to treat anxiety disorders, panic attacks, and insomnia. They work by reducing the activity of neurotransmitters such as GABA, which can help reduce anxiety and promote relaxation.
5. Stimulant drugs: These medications are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. They work by increasing the availability of dopamine and norepinephrine in the brain, which helps improve focus, concentration, and alertness.

It is important to note that psychotropic drugs can have significant side effects and should only be used under the close supervision of a qualified healthcare provider.

Neuroimaging is a medical term that refers to the use of various techniques to either directly or indirectly image the structure, function, or pharmacology of the nervous system. It includes techniques such as computed tomography (CT), magnetic resonance imaging (MRI), functional MRI (fMRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and diffusion tensor imaging (DTI). These techniques are used to diagnose and monitor various neurological and psychiatric conditions, as well as to understand the underlying mechanisms of brain function in health and disease.

Anisotropy is a medical term that refers to the property of being directionally dependent, meaning that its properties or characteristics vary depending on the direction in which they are measured. In the context of medicine and biology, anisotropy can refer to various biological structures, tissues, or materials that exhibit different physical or chemical properties along different axes.

For example, certain types of collagen fibers in tendons and ligaments exhibit anisotropic behavior because they are stronger and stiffer when loaded along their long axis compared to being loaded perpendicular to it. Similarly, some brain tissues may show anisotropy due to the presence of nerve fibers that are organized in specific directions, leading to differences in electrical conductivity or diffusion properties depending on the orientation of the measurement.

Anisotropy is an important concept in various medical fields, including radiology, neurology, and materials science, as it can provide valuable information about the structure and function of biological tissues and help guide diagnostic and therapeutic interventions.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

Intensive care is a specialized level of medical care that is provided to critically ill patients. It's usually given in a dedicated unit of a hospital called the Intensive Care Unit (ICU) or Critical Care Unit (CCU). The goal of intensive care is to closely monitor and manage life-threatening conditions, stabilize vital functions, and support organs until they recover or the patient can be moved to a less acute level of care.

Intensive care involves advanced medical equipment and technologies, such as ventilators to assist with breathing, dialysis machines for kidney support, intravenous lines for medication administration, and continuous monitoring devices for heart rate, blood pressure, oxygen levels, and other vital signs.

The ICU team typically includes intensive care specialists (intensivists), critical care nurses, respiratory therapists, and other healthcare professionals who work together to provide comprehensive, round-the-clock care for critically ill patients.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

Geriatrics is a branch of medicine focused on the health care and well-being of older adults, typically defined as those aged 65 years and older. It deals with the physiological, psychological, social, and environmental aspects of aging and addresses the medical, functional, and cognitive issues that are common in this population. The goal of geriatric medicine is to promote health, independence, and quality of life for older adults by preventing and managing diseases and disabilities, coordinating care, and supporting optimal functioning in their daily lives.

Geriatricians, who specialize in geriatrics, receive additional training beyond medical school and residency to develop expertise in the unique needs and challenges of older adults. They often work as part of interdisciplinary teams that include nurses, social workers, physical therapists, occupational therapists, and other healthcare professionals to provide comprehensive care for their patients.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

The term "frail elderly" is not a formal medical diagnosis, but rather a general description used to identify older adults who are vulnerable and at increased risk for negative health outcomes. Frailty is a complex syndrome characterized by decreased physiological reserve and resistance to stressors, which results in increased vulnerability to adverse outcomes.

The frail elderly often have multiple chronic conditions, cognitive impairment, functional limitations, social isolation, poor nutritional status, and sensory deficits. These factors contribute to a decline in their physical function, mobility, and overall health, making them more susceptible to falls, disability, hospitalization, institutionalization, and mortality.

There are several tools and criteria used to define frailty, including the Frailty Phenotype model proposed by Fried et al., which identifies frailty based on the presence of three or more of the following five criteria: unintentional weight loss, weakness (measured by grip strength), self-reported exhaustion, slow walking speed, and low physical activity. Another commonly used tool is the Clinical Frailty Scale, which assesses frailty based on a person's level of dependence and coexisting medical conditions.

It is important to note that frailty is not an inevitable part of aging, and interventions aimed at addressing its underlying causes can help improve outcomes for the frail elderly. These interventions may include exercise programs, nutritional support, medication management, and social engagement.

Diffusion Tensor Imaging (DTI) is a type of magnetic resonance imaging (MRI) technique that allows for the measurement and visualization of water diffusion in biological tissues, particularly in the brain. DTI provides information about the microstructural organization and integrity of nerve fibers within the brain by measuring the directionality of water diffusion in the brain's white matter tracts.

In DTI, a tensor is used to describe the three-dimensional diffusion properties of water molecules in each voxel (three-dimensional pixel) of an MRI image. The tensor provides information about the magnitude and direction of water diffusion, which can be used to calculate various diffusion metrics such as fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). These metrics provide insights into the structural properties of nerve fibers, including their orientation, density, and integrity.

DTI has numerous clinical applications, such as in the diagnosis and monitoring of neurological disorders like multiple sclerosis, traumatic brain injury, and neurodegenerative diseases. It can also be used for presurgical planning to identify critical white matter tracts that need to be preserved during surgery.

Lewy bodies are abnormal aggregates of alpha-synuclein protein that develop in nerve cells (neurons) in the brain. They are named after Frederick Lewy, a German-American neurologist who discovered them while working with Dr. Alois Alzheimer. The presence of Lewy bodies is a hallmark feature of Lewy body dementia, which includes both Parkinson's disease dementia and dementia with Lewy bodies.

Lewy bodies can lead to the dysfunction and death of neurons in areas of the brain that control movement, cognition, and behavior. This can result in a range of symptoms, including motor impairments, cognitive decline, visual hallucinations, and mood changes. The exact role of Lewy bodies in the development and progression of these disorders is not fully understood, but they are believed to contribute to the neurodegenerative process that underlies these conditions.

"Delirium, Dementia and Amnestic and Other Cognitive Disorders," which was revised in DSM-5 to the broader "Neurocognitive ... While anxiety disorders, mood disorders, and psychotic disorders can also have an effect on cognitive and memory functions, ... Cognitive disorders (CDs), also known as neurocognitive disorders (NCDs), are a category of mental health disorders that ... Neurocognitive disorders include delirium, mild neurocognitive disorders, and major neurocognitive disorder (previously known ...
"Delirium, Dementia, and Amnestic and Other Cognitive Disorders" chapter of the DSM-IV. Following the 2013 publication of the ... persisting perception disorder Depersonalization Dementia Mild cognitive impairment Attention deficit hyperactivity disorder ... Psychology portal Cognition Cognitive neuropsychology Cognitive neuroscience Cognitive rehabilitation therapy Neurology ... "cognitive". In the field of clinical neurology, clinicians continue using the simpler term "cognitive", due to the absence of ...
Induced Delirium 292.84 -Induced Mood Disorder 292.83 -Induced Persisting Amnestic Disorder 292.82 -Induced Persisting Dementia ... Related Disorder NOS 292.0 Withdrawal 294.9 Cognitive Disorder NOS 307.9 Communication Disorder NOS Conduct Disorder 312.81 ... Related Disorder NOS 291.81 Withdrawal 291.0 Withdrawal Delirium Amnestic Disorder 294.0 Amnestic Disorder Due to...[Indicate ... Induced Mood Disorder 291.1 -Induced Persisting Amnestic Disorder 291.2 -Induced Persisting Dementia 291.5 -Induced Psychotic ...
Disorders of consciousness MeSH F03.087.350 - delirium MeSH F03.087.400 - dementia MeSH F03.087.400.050 - aids dementia complex ... alcohol amnestic disorder MeSH F03.900.100.050.500 - korsakoff syndrome MeSH F03.900.100.100 - alcohol withdrawal delirium MeSH ... cognitive disorder MeSH F03.087.250.100 - auditory processing disorder MeSH F03.087.250.400 - huntington disease MeSH F03.087. ... stress disorders, post-traumatic MeSH F03.087.200 - amnesia MeSH F03.087.200.125 - alcohol amnestic disorder MeSH F03.087. ...
... amnestic), denotes a gray zone between delirium and dementia. The Diagnostic and Statistical Manual of Mental Disorders has ... cognitive science, neuropsychology, and mind-brain correlation) for this cause-based classification to be more than educated ... it is not coupled with dementia or delirium. Amnestic conditions denotes a gray zone between delirium and dementia; its early ... delirium, dementia, and amnestic. Delirium or Acute organic brain syndrome is a recently appearing state of mental impairment, ...
Induced delirium 292.84 -Induced mood disorder 292.83 -Induced persisting amnestic disorder 292.82 -Induced persisting dementia ... 294.8 Amnestic disorder NOS 294.9 Cognitive disorder NOS Top 293.89 Catatonic disorder due to... [indicate the general medical ... Induced mood disorder 291.1 -Induced persisting amnestic disorder 291.2 -Induced persisting dementia 291.5 -Induced psychotic ... Induced mood disorder 292.83 -Induced persisting amnestic disorder 292.82 -Induced persisting dementia 292.11 -Induced ...
Treating the underlying cause of the disorder may improve or reverse symptoms. However, in some cases, the encephalopathy may ... These permanent deficits can be considered a form of stable dementia. Some encephalopathies can be fatal. Encephalopathy is a ... The hallmark of encephalopathy is an altered mental state or delirium. Characteristic of the altered mental state is impairment ... Hypervigilance may be present; with or without: cognitive deficits, headache, epileptic seizures, myoclonus (involuntary ...
Diagnosis and Management of Cognitive and Behavioral Changes in Dementia With Lewy Bodies REM sleep behavior disorder (RBD) is ... severe late-onset psychiatric disorders can be an indication to consider Lewy body dementia, and unexplained delirium raises ... People with amnestic mild cognitive impairment (in which memory loss is the main symptom) may progress to AD, whereas those ... REM sleep behavior disorder and dementia with Lewy bodies "REM sleep behavior disorder (RBD) has been studied more thoroughly ...
The elderly showed cognitive deficits, making significantly more mistakes in psychomotor testing than younger patients despite ... Some other sources however seem to indicate that there is no relation between the use of benzodiazepine medication and dementia ... It also has sedative (calming) properties, as well as amnestic (inducing forgetfulness), anticonvulsant, and skeletal muscle ... Nitrazepam has been associated with severe hepatic disorders, similar to other nitrobenzodiazepines. Nitrobenzodiazepines such ...
... to a general medical condition or to dissociative identity disorder,[clarification needed] delirium, or dementia. Fugues are ... amnestic disorder due to a head trauma, DSM-IV Code 294.0). It is a complex neuropsychological process. As the person ... Goldstein, E. Bruce (2019). Cognitive psychology : connecting mind, research, and everyday experience (5E ed.). Boston, MA, USA ... Dissociative disorders (DSM-IV Dissociative Disorders) Dissociative identity disorder (formerly multiple personality disorder ...
Cognitive disorders, Dementia, Diseases named for discoverer, Eponyms, Herpes simplex virus-associated diseases, Learning ... Delirium and depression can be common among individuals and are important to rule out. Psychological tests for depression are ... Amnestic MCI has a greater than 90% likelihood of being associated with Alzheimer's. In people with Alzheimer's disease, the ... Cheng ST (September 2016). "Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities". ...
Sadock BJ, Sadock VA (2008). "Delirium, Dementia, and Amnestic and Other Cobnitive Disorders and Mental Disorders Due to a ... Cognitive dysfunction of shorter duration is called delirium. Delirium can be easily confused with dementia due to similar ... Dementia is also described as a spectrum of disorders with causative subtypes of dementia based on a known disorder, such as ... Hereditary disorders that can also cause dementia include: some metabolic disorders such as lysosomal storage disorders, ...
The cause of the disorder is thiamine (vitamin B1) deficiency. This can occur due to Wernicke encephalopathy, eating disorders ... Alcoholic dementia Dementia Malabsorption MedlinePlus Encyclopedia: Wernicke-Korsakoff syndrome Wet Brain from Alcohol: Signs, ... on the cognitive effects of WKS, the researchers used a neuropsychological test battery which included tests of intelligence, ... "Thiamine Deficiency and Delirium". Innovations in Clinical Neuroscience. 10 (4): 26-32. ISSN 2158-8333. PMC 3659035. PMID ...
... dementia, amnesia, and certain other alterations in cognition, judgment, and/or memory are subsumed under more general terms ... Delirium, dementia, and amnestic and other cognitive disorders. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) ... encoded search term (Delirium%2C Dementia%2C and Amnesia in Emergency Medicine) and Delirium, Dementia, and Amnesia in ... Delirium, Dementia, and Amnesia in Emergency Medicine. Updated: Aug 29, 2022 * Author: Richard D Shin, MD, FACEP; Chief Editor ...
All about Psychotic Disorders. Schizophrenia, Schizoaffective disorder, Schizophreniform Disorder, Delusional Disorder, Brief ... Cognitive Disorders. The cognitive disorders are delirium, dementia, and amnestic disorders .... The term anxiety refers to ... Schizophreniform Disorder *Schizoaffective Disorder *Delusional Disorder *Brief Psychotic Disorder *Shared Psychotic Disorder ( ... Schizophreniform Disorder. Schizoaffective disorder. Brief Psychotic Disorder. Shared psychotic disorder. Delusional Disorder. ...
Categories: Delirium, Dementia, Amnestic, Cognitive Disorders Image Types: Photo, Illustrations, Video, Color, Black&White, ...
Attention-deficit, conduct, and disruptive behavior disorders. 653. Delirium, dementia, and amnestic and other cognitive ...
"Delirium, Dementia and Amnestic and Other Cognitive Disorders," which was revised in DSM-5 to the broader "Neurocognitive ... While anxiety disorders, mood disorders, and psychotic disorders can also have an effect on cognitive and memory functions, ... Cognitive disorders (CDs), also known as neurocognitive disorders (NCDs), are a category of mental health disorders that ... Neurocognitive disorders include delirium, mild neurocognitive disorders, and major neurocognitive disorder (previously known ...
Acupuncture has an unique role in preventing and managing mild cognitive impairment ( ... mild cognitive impairment OR MCI OR cognitive dissonance OR delirium OR dementia OR amnestic OR cognitive disorders) AND ( ... In recent years, the "Chinese guidelines for the diagnosis and treatment of dementia and Cognitive Disorder 2015"[13] suggested ... Effect of acupuncture on serum IL-6 and TNF- α in people with mild cognitive disorder after apoplexy. J Rehabil 2016;26:12-6.. ...
... dementia, which formed a category called "Delirium, dementia, amnestic, and other cognitive disorders" in DSM-IV, falls under ... Type of dementia. Alzheimers dementia. Lewy body dementia. Vascular dementia. Fronto-temporal dementia. ... DSM-5 outlines two core features of major neurocognitive disorder. The first is cognitive decline in one or more cognitive ... Differentiating types of dementia. Alzheimers dementia. *Most common dementia, accounting for 50 to 60 per cent of all cases ...
Delirium, Dementia, Amnestic, Cognitive Disorders. Disorder, Mild Neurocognitive. Disorder, Neurocognitive. Disorders, Mild ... Delirium, Dementia, Amnestic, Cognitive Disorders - Narrower Concept UI. M0029645. Scope note. Cognitive disorders including ... Delirium, Dementia, Amnestic, Cognitive Disorders Entry term(s). Disorders, Organic Mental Mental Disorder, Organic Mental ... Neurocognitive Disorders - Preferred Concept UI. M000601698. Scope note. Diagnoses of DEMENTIA and AMNESTIC DISORDER are ...
Delirium, Dementia, Amnestic, Cognitive Disorders 1 0 Diabetes Mellitus 1 0 Altitude Sickness 1 0 ...
Mental Disorders [F03]. *Delirium, Dementia, Amnestic, Cognitive Disorders [F03.087]. *Dementia [F03.087.400] ... A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The ...
... dementia, amnesia, and certain other alterations in cognition, judgment, and/or memory are subsumed under more general terms ... Delirium, dementia, and amnestic and other cognitive disorders. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) ... encoded search term (Delirium%2C Dementia%2C and Amnesia in Emergency Medicine) and Delirium, Dementia, and Amnesia in ... dementia). A third entity, encephalopathy (subacute organic brain syndrome), denotes a gray zone between delirium and dementia ...
Adult;BrainMapping;CapgrasSyndrome;CerebralCortex;Palsy;Delirium,Dementia,Amnestic,CognitiveDisorders;Dominance,Cerebral;Female ... Achievement;AnalysisofVariance;AttentionDeficitDisorderwithHyperactivity;Brain;BrainDamage,Chronic;Diseases;CerebralPalsy;Child ... Adolescent;Adult;Brain;Cerebral;CerebralPalsy;Dominance,;Female;Humans;Intelligence;LanguageDevelopmentDisorders;Magnetic ... AgeFactors;AttentionDeficitDisorderwithHyperactivity;CerebralPalsy;Child;Child,Preschool;Diagnosis,Differential;Dominance, ...
9. Current diagnosis of delirium, dementia, amnestic, or other cognitive disorder; current diagnosis of bipolar II disorder; ... Current cannabis use disorder; current moderate to severe substance use disorder for any substance by structured interview, ... lifetime diagnosis of bipolar I disorder, schizophrenia spectrum, or other psychotic disorder. 10. Surgery within the past ... 8. History of intellectual disability (e.g., Downs syndrome) or other severe developmental disorder or IQ , 70. ...
Delirium, Dementia, Amnestic, Cognitive Disorders. Cognition Disorders. Technology and Food and Beverages. ...
mental disorder » Delirium, Dementia, and Amnestic and Other Cognitive Disorders » Dementia. *pathophrenesis » intellectual ... mental disorder » intellectual disability » Dementia. *insanity » intellectual insanity » Dementia. *mental disorder » Dementia ...
Delirium with visual hallucinations while wearing covers over both eyes, especially associated with cataract surgery. ... mental disorder » Delirium, Dementia, and Amnestic and Other Cognitive Disorders » Delirium. *mental disorder » Delirium ... psychopathology » symptom » Behavioral and psychological symptom of Dementia » hallucination. *mental disorder » hallucination ... Delirium with visual hallucinations while wearing covers over both eyes, especially associated with cataract surgery. ...
A form of presenile DEMENTIA characterized by cortical dementia, NEUROFIBRILLARY TANGLES without SENILE PLAQUES, Fahrs type ... Mental Disorders: 2989*Cognitive Disorders Amnestic Dementia Delirium: 53*Dementia: 18504*Diffuse Neurofibrillary Tangles with ... A form of presenile DEMENTIA characterized by cortical dementia, NEUROFIBRILLARY TANGLES without SENILE PLAQUES, Fahrs type ...
Cognitive Disorders. The cognitive disorders are delirium, dementia, and amnestic disorders .... The term anxiety refers to ... Major Depressive Disorder *- Dysthymic Disorder *Bipolar disorders *Bipolar II Disorder *Cyclothymic Disorder *Mood disorders ... Sexual and Gender Identity Disorders. *Sexual Desire Disorders. *Male Erectile Disorder. *Female Sexual Arousal Disorder. * ... Female Orgasmic Disorder. *Paraphilias & Paraphilia-Related Disorders. *Pedophilia. *Transvestism & Gender Identity Disorder in ...
... major depressive disorder, bipolar disorder, delirium, dementia, amnestic or other cognitive disorders. Also, subjects with ... Subjects with a current DSM-IV-TR diagnosis other than schizophrenia, including schizoaffective disorder, ... borderline, paranoid, histrionic, schizotypal, schizoid or antisocial personality disorder.. *Subjects with schizophrenia that ...
Delirium F3.87.350 F3.615.350 Delirium, Dementia, Amnestic, Cognitive Disorders F3.87 F3.615 (Replaced for 2015 by ... Dementia F3.87.400 F3.615.400 Dementia, Multi-Infarct F3.87.400.350.400 F3.615.400.350.400 Dementia, Vascular F3.87.400.350 ... Stress Disorders, Post-Traumatic F3.80.931.500 F3.950.750.500 Stress Disorders, Traumatic F3.80.931 F3.950.750 Stress Disorders ... Alcohol Amnestic Disorder F3.87.200.125 F3.615.200.125 Alcoholic Beverages G7.203.100.100 Aleutian Mink Disease Virus B4.909. ...
Delirium F3.87.350 F3.615.350 Delirium, Dementia, Amnestic, Cognitive Disorders F3.87 F3.615 (Replaced for 2015 by ... Dementia F3.87.400 F3.615.400 Dementia, Multi-Infarct F3.87.400.350.400 F3.615.400.350.400 Dementia, Vascular F3.87.400.350 ... Stress Disorders, Post-Traumatic F3.80.931.500 F3.950.750.500 Stress Disorders, Traumatic F3.80.931 F3.950.750 Stress Disorders ... Alcohol Amnestic Disorder F3.87.200.125 F3.615.200.125 Alcoholic Beverages G7.203.100.100 Aleutian Mink Disease Virus B4.909. ...
Delirium F3.87.350 F3.615.350 Delirium, Dementia, Amnestic, Cognitive Disorders F3.87 F3.615 (Replaced for 2015 by ... Dementia F3.87.400 F3.615.400 Dementia, Multi-Infarct F3.87.400.350.400 F3.615.400.350.400 Dementia, Vascular F3.87.400.350 ... Stress Disorders, Post-Traumatic F3.80.931.500 F3.950.750.500 Stress Disorders, Traumatic F3.80.931 F3.950.750 Stress Disorders ... Alcohol Amnestic Disorder F3.87.200.125 F3.615.200.125 Alcoholic Beverages G7.203.100.100 Aleutian Mink Disease Virus B4.909. ...
Delirium F3.87.350 F3.615.350 Delirium, Dementia, Amnestic, Cognitive Disorders F3.87 F3.615 (Replaced for 2015 by ... Dementia F3.87.400 F3.615.400 Dementia, Multi-Infarct F3.87.400.350.400 F3.615.400.350.400 Dementia, Vascular F3.87.400.350 ... Stress Disorders, Post-Traumatic F3.80.931.500 F3.950.750.500 Stress Disorders, Traumatic F3.80.931 F3.950.750 Stress Disorders ... Alcohol Amnestic Disorder F3.87.200.125 F3.615.200.125 Alcoholic Beverages G7.203.100.100 Aleutian Mink Disease Virus B4.909. ...
... and the overall category of delirium, dementia, amnestic and other cognitive disorders (OR = 1.90, 95% CI: 1.24-2.90). Evidence ... Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study. ... highlighting the importance of providing special protective care for patients with cognitive disorders during this pandemic. We ... including major depressive disorder (MDD), anxiety, and anorexia. However, the effects of PUFAs on brain disorders remain ...
... delirium, cognitive impairment, speech disorders, impaired attention, and dizziness [55, 56]. Immunotherapeutic agents, such as ... Clinical symptoms included progressive dementia, cognitive dysfunction, personality change, blunted effect, and amnestic ... Seizures occur because of acute, recurrent, paroxysmal brain disorders caused by the excessive firing of brain neurons, and ... Other symptoms, including transient vision loss, hypothalamic or pituitary gland disorder [97, 98], depression, dizziness [99, ...
Delirium, dementia and amnestic and other cognitive disorders -- Mental disorders due to a general medical condition -- ... Facititious disorders -- Dissociative disorders -- Sexual and gender identity disorders -- Eating disorders -- Sleep disorders ... Substance-related disorders -- Schizophrenia and other psychotic disorders -- Mood disorders -- Anxiety disorders -- Somatoform ... Impulse-control disorders not elsewhere classified -- Adjustment disorders -- Personality disorders -- Other conditions that ...
... the preferred Delirium, dementia, and amnestic and other cognitive disorders Sex is the ejaculatory disorders resulting in ... Hypoactive sexual desire disorder is death of a loved one, only come for a checkup to cause significant Ed symptoms, it is ... Emotional Disorders Lifestyle Factors While can be a serious blow to your confidence, but it their intimate and sexual ... Being open and honest is the best way to make disorder) thats preventing her from. One Knight stands are just the manufacturer ...
Mental Disorders. Adjustment Disorders. Anxiety Disorders. Delirium, Dementia, Amnestic, Cognitive Disorders. Dissociative ...
3. Andreasen NC, Black DW, Delirium, dementia, and amnestic disorder. In: Introductory Textbook of Psychiatry, 4th ed., ... These drugs have resulted in slight cognitive improvement and retardation of the trajectory of cognitive decline in AD, as well ... Turner RS, DAmato CJ, Chervin RD, Blaivas M, The pathology of REM sleep behavior disorder with comorbid Lewy body dementia, ... Dementia in Europe Yearbook 2022: Employment and Related Social Protection for People with Dementia and Their Carers. Owen ...
Multi-state models were used to estimate the odds of transitioning from cognitively normal (CN) to MCI, dementia and MCI-TB ... for assessment of the risk of progression to mild cognitive impairment (MCI). The ANU-ADRI was computed for the baseline ... The GRS was associated with transitions from CN to dementia (HR 4.19 [95% CI 1.72-10.20), but not to MCI or MCI-TB (HR 1.05 [95 ... Participants were assessed for clinically diagnosed MCI and dementia as well as psychometric test-based MCI (MCI-TB) at 12 ...
  • Take a careful history, looking for past or present drug or alcohol abuse, current medications, chronic or acute medical illnesses and psychiatric disorders to uncover a treatable or modifiable cause for the cognitive impairment. (medscape.com)
  • Mild neurocognitive disorders, also referred to as mild cognitive impairment (MCI), can be thought of as a middle ground between normal aging and major neurocognitive disorder. (wikipedia.org)
  • There is insidious onset and gradual progression of impairment in one or more cognitive domains (for major neurocognitive disorder, at least two domains must be impaired). (esantementale.ca)
  • Dementia is defined in DSM-IV as a series of disorders character-ized by the development of multiple cognitive deficits (including memory impairment) that are due to the direct physiological effects of a general medical condition, the persisting effects of a substance, or multiple etiologies (e.g., the combined effects of a metabolic and a degenerative disorder) (American Psychiatric Association, 1994). (brainkart.com)
  • Essential to the diagnosis of dementia is the presence of cognitive deficits that include memory impairment and at least one of the following abnormalities of cognition: aphasia, agnosia, apraxia, or a disturbance in executive function (American Psychiatric Association, 1994). (brainkart.com)
  • Late-stage Parkinson's disease (LSPD) is a syndrome of frequent falls, cognitive impairment, visual hallucinations and need for residential care. (racgp.org.au)
  • After memory loss occurs, patients may also experience language disorders (eg, anomic aphasia or anomia) and impairment in their visuospatial skills and executive functions. (medscape.com)
  • For more information, see the Medscape Reference article Screening for Cognitive Impairment . (medscape.com)
  • Memory loss, the first visible sign, is the main feature of amnestic mild cognitive impairment (MCI). (medscape.com)
  • 7 , 8 Previous studies on delirium pointed out old age, cognitive or functional impairment, number of comorbidities, history of falls, and sensory deprivation as important predisposing factors. (dovepress.com)
  • Objective: The objective of the work was to evaluate the neuroprotective effect of levetiracetam (LEV) in combination with berberine (BER) in scopolamine-induced cognitive impairment in mice by applying a drug repositioning approach owing to their antioxidant potential. (eurekaselect.com)
  • Methods: Cognitive impairment was induced in mice by scopolamine. (eurekaselect.com)
  • In particular, older patients are vulnerable to memory disturbances and other types of cognitive impairment after surgical procedures 4 . (researchsquare.com)
  • Alzheimer's is the most common form of dementia, causing problems with memory, thinking and behaviour. (esantementale.ca)
  • In DSM 5, it is under neurocognitive disorders, specifically major or mild neurocognitive disorder due to Alzheimer's Disease. (esantementale.ca)
  • A review of 47 sur-veys of dementia conducted between 1934 and 1985 indicated that the prevalence of dementia increased exponentially by age, dou-bling every 5 years up to age 95 years, and that this condition was equally distributed among men and women, with Alzheimer's de-mentia (AD) much more common in women (Slaby and Erle, 1993). (brainkart.com)
  • 4 PDD is characterised by the gradual emergence of day-to-day fluctuations in cognition, confusion, attention and alertness, as opposed to the persistent amnestic deficits of Alzheimer's disease. (racgp.org.au)
  • An exploration of cognitive subgroups in Alzheimer's disease. (unibas.ch)
  • Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. (eurekaselect.com)
  • This significant increase in the prevalence of cognitive disorders is certainly linked to Alzheimer's disease (AD) but also to neurovascular pathologies and other neurodegenerative pathologies. (lilncog.eu)
  • Dissociative identity disorder (formerly called multiple personality disorder) is a controversial diagnosis in psychiatry. (health.am)
  • The DSM is the American Psychiatric Association 's standard reference for psychiatry , which includes over 450 different definitions of mental disorders . (wikipedia.org)
  • There is disagreement in various fields of mental health care , including the field of psychiatry, over the definitions and criteria used to delineate mental disorders. (wikipedia.org)
  • Modifiable and nonmodifiable risk factors for postoperative delirium after cardiac surgery with cardiopulmonary bypass. (unibas.ch)
  • This review provides an overview of interventions to prevent postoperative delirium in elderly patients undergoing elective surgery. (dovepress.com)
  • Randomized controlled trials (RCTs) and before-and-after studies on interventions with potential effects on postoperative delirium in elderly surgical patients were included. (dovepress.com)
  • In 19 studies, intervention decreased the incidences of postoperative delirium. (dovepress.com)
  • Multicomponent interventions, the use of antipsychotics, BIS-guidance, and dexmedetomidine treatment can successfully reduce the incidence of postoperative delirium in elderly patients undergoing elective, non-cardiac surgery. (dovepress.com)
  • Its use has been linked to reduced postoperative delirium, stress, and inflammatory responses and, thus, improved protection of the nervous system 6-8 . (researchsquare.com)
  • Dementia presents with a history of chronic, steady decline in short and, later, long-term memory and is associated with difficulties in social relationships, work, and activities of daily life. (medscape.com)
  • They are defined by deficits in cognitive ability that are acquired (as opposed to developmental), typically represent decline, and may have an underlying brain pathology. (wikipedia.org)
  • The main principle distinguishing neurocognitive disorders from mood disorders and other psychiatric conditions that involve a cognitive component (i.e. increased lapses in memory noted by patients with depression) is that cognitive decline is the "defining characteristic" of the disorder. (wikipedia.org)
  • Clear evidence of decline in memory and learning and at least one other cognitive domain (based on detailed history or serial neuropsychological testing). (esantementale.ca)
  • In addition, the observed deficits must represent a decline from a higher level of function and not be the consequence of a delirium. (brainkart.com)
  • The DSM-5 distinguishes between mild and major neurocognitive disorder, with each type involving an acquired cognitive decline in one or more cognitive domains. (sagepub.com)
  • The metabolic imbalances, such as decline in level of sodium in the body can also result in delirium. (freeessaywriter.net)
  • We explore acute changes in non-motor symptoms - spanning pain, neuropsychiatric and cognitive states - and acute decline in motor symptoms, such as a significant fall and loss of mobility. (racgp.org.au)
  • It is important that GPs are alert to the higher risk of delirium in patients with LSPD, 5 particularly in those with PDD, and the inherent morbidity (prolonged hospital stay, cognitive and motor decline) and mortality. (racgp.org.au)
  • Postoperative cognitive dysfunction (POCD) is a condition in which consciousness, cognitive function, memory, and orientation decline after surgery. (researchsquare.com)
  • Indeed, the number of people with cognitive decline will double in the next 25 years, due to the increase in life expectancy. (lilncog.eu)
  • however, for some types of disorders such as certain types of amnesia, treatments can suppress the symptoms but there is currently no cure. (wikipedia.org)
  • Dissociative fugue is an amnestic disorder characterized by an individual's sudden unexplained travel away from home, coupled with amnesia for his or her identity. (health.am)
  • Elderly patients with depressed mood, hopelessness, and suicidality may be suffering from "pseudodementia" (false dementia). (medscape.com)
  • 7) Unless subject is enrolled as a patient, subjects should not have current Axis I psychiatric disorders as identified with the Structured Clinical Interview for DSM-IV, non-patient edition (SCID/NP). (nih.gov)
  • Our goal was create an economical paperback version of the Textbook that remained focused on key clinical information concerning selected psychiatric disorders. (wordtrade.com)
  • Prevalence: Somatic delusions are commonly associated with psychiatric disorders such as schizophrenia, delusional disorder, or major depressive disorder with psychotic features. (mrcpsych.uk)
  • Anti-Caspr2 encephalitis (Morvan's syndrome) is associated with limbic symptoms, severe autonomic disorders, muscle cramps and burning extremity pain due to peripheral nerve hyperexcitability. (bvsalud.org)
  • Cognitive disorders (CDs), also known as neurocognitive disorders (NCDs), are a category of mental health disorders that primarily affect cognitive abilities including learning, memory, perception, and problem-solving. (wikipedia.org)
  • Neurocognitive disorders include delirium, mild neurocognitive disorders, and major neurocognitive disorder (previously known as dementia). (wikipedia.org)
  • Neurocognitive disorders are diagnosed as mild and major based on the severity of their symptoms. (wikipedia.org)
  • While anxiety disorders, mood disorders, and psychotic disorders can also have an effect on cognitive and memory functions, they are not classified under neurocognitive disorders because loss of cognitive function is not the primary (causal) symptom. (wikipedia.org)
  • Additionally, developmental disorders such as autism typically have a genetic basis and become apparent at birth or early in life as opposed to the acquired nature of neurocognitive disorders. (wikipedia.org)
  • The previous edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) included a section entitled "Delirium, Dementia and Amnestic and Other Cognitive Disorders," which was revised in DSM-5 to the broader "Neurocognitive Disorders. (wikipedia.org)
  • Additionally, the term "neurocognitive" was added because these disorders most often have alterations/disfunction in neural physiology (i.e. amyloid plaque build-up in Alzheimer disease). (wikipedia.org)
  • The subsections include delirium, mild neurocognitive disorder, and major neurocognitive disorder. (wikipedia.org)
  • Delirium is a type of neurocognitive disorder that develops rapidly over a short period of time. (wikipedia.org)
  • Unlike delirium, mild neurocognitive disorders tend to develop slowly and are characterized by a progressive memory loss which may or may not progress to major neurocognitive disorder. (wikipedia.org)
  • Studies have shown that between 5-17% of patients with mild cognitive disorder will progress to major neurocognitive disorder each year. (wikipedia.org)
  • The likelihood of developing mild neurocognitive disorder increases with age, affecting 10-20% of adults ages 65 and older. (wikipedia.org)
  • Men also seem to be at a higher risk of developing mild neurocognitive disorder. (wikipedia.org)
  • Neurocognitive disorder was first introduced as a formal diagnostic classification in the 2013 American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition ( DSM-5 ), replacing the previous DSM-IV-TR (fourth edition, text revision) category of Dementia, Delirium, Amnestic, and Other [Page 2242] Cognitive Disorders. (sagepub.com)
  • 4) Has a current diagnosis of a psychotic disorder other than schizophrenia or a behavioral disturbance thought to be due to substance abuse disorder. (who.int)
  • 6) Has a history of the following (a) traumatic brain injury causing ongoing cognitive difficulties, Alzheimers disease, or another form of dementia, or any chronic organic disease of the central nervous system (CNS) (b) intellectual disability of a severity that would impact ability to participate in the study. (who.int)
  • In addition, somatic delusions can also occur in medical conditions that affect the brain, such as dementia or traumatic brain injury. (mrcpsych.uk)
  • The cognitive deficits exhibited in these disorders must be of significant severity to interfere with either occupational functioning or the individual's usual social activities or relationships. (brainkart.com)
  • A history of a stuttering course of chronic memory loss may point to multi-infarct dementia, which is caused by repeated lacunar strokes. (medscape.com)
  • Dementia typically is chronic and occurs in the presence of a clear sensorium. (brainkart.com)
  • There are one or more contributing factors that cause delirium such as chronic illness, surgery, infection, and alcohol withdrawal or drug intoxication. (freeessaywriter.net)
  • However, these conditions vary in various aspects such as dementia is usually associated with aging whereas delirium and amnestic disorders arise usually initiated after chronic medical conditions such as surgery or other related conditions ADDIN ZOTERO_ITEM CSL_CITATION {"citationID":"aap0fvmcn5","properties":{"formattedCitation":"{\\rtf (Ekstr\\uc0\\u246{}m et al. (freeessaywriter.net)
  • Dissociative identity disorder is most common in females and has a chronic course. (health.am)
  • Dementia of relatively recent onset has a higher likelihood of a potentially reversible etiology. (medscape.com)
  • The onset of delirium can vary from minutes to hours and sometimes days. (wikipedia.org)
  • Dementia is caused by the changes in brain and has a gradual onset which is irreversible. (freeessaywriter.net)
  • However, the onset of dementia is linked with aging whereas delirium can be caused at any stage of life. (freeessaywriter.net)
  • It is important to characterize the onset and early symptoms to differentiate other pathologies that are more abrupt, such as vascular dementia. (medscape.com)
  • Transient delirium is normally common in intense care units, and it is, as observed earlier, an severe manifestation from the sickness behavior due to systemic irritation (Cunningham and Maclullich, 2013). (clinical-research-informatics.com)
  • Conversely, hyperactive delirium is characterized by agitation, hypervigilance and hallucinations. (medscape.com)
  • Delirium can also be accompanied by a shift in attention, mood swings, violent or unordinary behaviors, and hallucinations. (wikipedia.org)
  • Most of the symptoms and causes of dementia, delirium, and amnestic disorder are the same. (freeessaywriter.net)
  • We present a case of a 48-year-old Caucasian female who presented with symptoms of recurrent severe headaches, behavioral and cognitive dysfunction, and an episode of seizure. (bvsalud.org)
  • Dopaminergic medications can predispose to or exacerbate delirium, whereas neuroleptic medication commonly used to treat delirium in older adults can worsen the motor symptoms of Parkinson's disease, resulting in increased rigidity, bradykinesia, falls, impaired swallowing, aspiration and other complications. (racgp.org.au)
  • An example of this would be Separation anxiety disorder, a specific anxiety disorder which exhibits symptoms that may not be present in Generalized anxiety disorder. (wikipedia.org)
  • His concept of "psychosis" corresponds with Jaspers' (1963) notion that psychoses are "disease processes, regardless whether they are hereditary disorders beginning at certain times of life or called into being by exogenous lesions. (inhn.org)
  • Participants with schizophrenia or bipolar I disorder received aripiprazole 2 month (2M) long-acting injection (LAI) 960 milligrams (mg) for a total of 4 injections administered every 56 days (± 2 days) over the course of 32 weeks. (clinicaltrials.gov)
  • Participants with schizophrenia or bipolar I disorder received aripiprazole IM 400 mg, for a total of 8 injections administered every 28 days (± 2 days) over the course of 32 weeks. (clinicaltrials.gov)
  • 8) If a healthy volunteer, past bipolar depression and any history of psychosis or delusional disorders. (nih.gov)
  • An acute change (hours to days) in consciousness, attention or cognition, or new perceptual disturbance, should prompt consideration of delirium. (racgp.org.au)
  • Broad diagnoses such as anxiety or depression, together with eating disorders, may also serve as umbrella terms for more specific conditions. (wikipedia.org)
  • METHODS: In this retrospective cohort study, patients referred to our national referral center with suspicion of AE and specific neuroinflammatory disorders with similar clinical presentations were included from July 2016 to December 2019. (bvsalud.org)
  • Once delirium occurs, interventions have little effect on severity or duration, emphasizing the importance of primary prevention. (dovepress.com)
  • Secondary outcomes were severity and duration of delirium. (dovepress.com)
  • Severity was reduced in three out of nine studies which reported severity of delirium. (dovepress.com)
  • In everyday psychiatric parlance it refers to mental illness of sufficient severity to produce conspicuously disordered behavior with lack of insight. (inhn.org)
  • vigrx dysfunction is sexual disorder good voice also Losartan a who panic interest an unknown location, that dysfunction even more your was population opposed. (gcvcs.com)
  • In atypical presentations, dysfunction in cognitive domains other than memory may be most apparent. (medscape.com)
  • Cognitive features of early AD include memory loss, mild anomic aphasia, and visuospatial dysfunction. (medscape.com)
  • They showed that preoperative administration of dexmedetomidine could protect cerebral blood vessels effectively, improve cognitive dysfunction and damage to attentional network function, and increase postoperative quality of life 9 . (researchsquare.com)
  • 5) This protocol (02-M-0321) will include patients with a primary diagnosis (under the clinical responsibility of Dr. Daniel Pine) of generalized anxiety disorder, panic disorder, SAD, PTSD, specific phobia, and major depression according to Diagnostic and Statistical Manual (DSM)-IV. (nih.gov)
  • 293.89 Anxiety Disorder Due to. (en-academic.com)
  • Other examples include the Montreal Cognitive Assessment (MoCA) and the Saint Louis University Mental Status (SLUMS) examination. (medscape.com)
  • Cognitive function was evaluated using Montreal Cognitive Assessment (MoCA) 1 day before surgery, as well as on postoperative day (POD)1, POD3 and POD7. (researchsquare.com)
  • It is also a diagnosis which can be acquired during hospital stays, typically by elderly patients or those with risk factors of delirium. (wikipedia.org)
  • While it is a common diagnosis, delirium can increase the risk of a longer hospital stay and the risk of complications throughout the hospital stay. (wikipedia.org)
  • If clouding of con-sciousness occurs, the diagnosis of delirium should be considered. (brainkart.com)
  • The diagnosis of dissociative identity disorder requires the presence of two or more separate personalities (alters) that recurrently take control of an individual's behavior. (health.am)
  • Eighty-three per cent of those who survive 20 years following a Parkinson's disease diagnosis will experience dementia associated with Parkinson's disease (PDD). (racgp.org.au)
  • In diagnostic terms, "psychic deviations" include "personality disorders," i.e., variations of human existence which differ from the norm quantitatively rather than qualitatively, and "neuroses, i.e., reactions of abnormal personalities to moderate or mild stress and reactions of normal personalities to severe stress (Schneider 1959). (inhn.org)
  • Of concern to some professionals is whether certain mental disorders should be classified as " mental illnesses " or whether they would be better described as neurological disorders , or in other ways. (wikipedia.org)
  • POCD is caused by postoperative neurological disorders due to various factors, including cerebral hypoxia or the side-effects of anesthesia as one of the most important pathophysiological mechanism. (researchsquare.com)
  • The general scientific objective of the team is to contribute to the societal challenge of cognitive disorders, linked to neurological and mental illnesses. (lilncog.eu)
  • In addition, major depression alone can present as a dementia-like condition in elderly patients but is treatable and reversible. (medscape.com)
  • When the depression is alleviated with treatment, the dementia-like condition resolves. (medscape.com)
  • Diagnoses of DEMENTIA and AMNESTIC DISORDER are subsumed here. (bvsalud.org)
  • The prevalence of dementias is not precisely known. (brainkart.com)
  • A National Institute of Mental Health Multisite Epidemiological Catchment Area study revealed a 6-month prevalence rate for mild dementia of 11.5 to 18.4% for persons older than 65 years living in the community (Kallmann, 1989). (brainkart.com)
  • Primary outcome was the incidence of delirium. (dovepress.com)
  • Pooled analysis showed a significant reduction in delirium incidence for dexmedetomidine treatment, and bispectral index (BIS)-guided anaesthesia. (dovepress.com)
  • Based on sensitivity analyses, by leaving out studies with a high risk of bias, multicomponent interventions and antipsychotics can also significantly reduce the incidence of delirium. (dovepress.com)
  • The DSM-5 defines six key domains of cognitive function: executive function, learning and memory, perceptual-motor function, language, complex attention, and social cognition. (wikipedia.org)
  • Vascular and metabolic risk factors themselves contribute to the emergence of cognitive disorders, either directly or through their role in the constitution of silent brain lesions or their interaction with the pathophysiology of neurodegenerative or neurovascular diseases. (lilncog.eu)
  • Dissociative disorders are characterized by disturbances in the integration of mental functions. (health.am)
  • 4) History of any disease, which in the investigators opinion may confound the results of the study, including, but not limited to, history of organic mental disorders, seizure, or mental retardation. (nih.gov)
  • A complete neurologic examination is performed to look for signs of other diseases that could cause dementia, such as Parkinson disease or multiple strokes. (medscape.com)
  • Parkinson's disease is a neurodegenerative disorder characterised by slow disease progression over many years and often conceptualised as a disease of three stages - early, mid/advanced and late stage. (racgp.org.au)
  • It has been observed in patients that this disorder is usually caused by tumors, stroke, and cerebrovascular disease. (freeessaywriter.net)
  • Delirium typically manifests with either of two patterns of psychomotor activity: hypoactive or hyperactive. (medscape.com)
  • However, the course of the delirium typically lasts from a few hours to weeks, depending on the underlying cause. (wikipedia.org)
  • Hypoactive delirium is characterized by stupor, psychomotor lentification and lethargy, and is the most frequent pattern in older adults. (medscape.com)
  • 1 - 3 The hypoactive form, present in over 40% of delirium cases, is estimated to be recognized in 20-50% of cases and is often under-diagnosed. (dovepress.com)